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Abstract
Stereotactic radiation therapy such as SRS and SBRT utilise multiple beams
delivery with a small radiation field and high dose gradients. A quality
assurance tool with high stability and linearity of radiation response that can
map a 2D dose read out in real time and with a high spatial resolution is needed
to accurately verify two-dimensional (2D) pre-treatment dose distributions.
This thesis describes two 2D monolithic diode arrays based on different silicon
substrates called MagicPlate-512 (MP512) designed and developed by the
Centre for Medical Radiation Physics to verify small field dosimetry. The first
substrate is based on bulk p-type silicon known as MP512-Bulk and the other
is based on the high resistivity of a thin epitaxial layer known as MP512-EPI.
MP512 allows real time 2D dose mapping with a high spatial and temporal
resolution. Both detector arrays consist of 512 0.5x0.5 mm2 active pixels with
a 2 mm pitch that covers an area of 52x52 mm2. The angular response of
MP512-Bulk as well as its correction factor were investigated for various field
sizes and photon energies. It showed a maximum variation of relative angular
response normalised to an incidence beam angle zero at a beam angle of 90° of
approximately 18.5±0.5% and 15.5±0.5% for 6 MV and 10 MV photon beams.
These results indicate that the angular response is sensitive to the energy,
whereas the variation of angular response is less affected by field size. The
packaging and intrinsic asymmetry of the monolithic silicon detector array
structure are the major elements that affect the angular dependence of an
MP512-Bulk. A comparison of the cross-plane profiles measured by the
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corrected MP512-Bulk and EBT3 shows an agreement within ±2% for all field
sizes, which proves that its correction factor and procedures can be applied to
small field sizes.
A full dosimetric characterisation of an MP512-EPI was carried out in terms of
the radiation hardness, percentage depth dose, dose linearity, dose per pulse
dependence, output factors for small field sizes, segmental dose linearity
measurement, and the angular response for 6 MV and 10 MV photon beams; it
was also studied for the dose rate dependence of 6 MV photon and 6 MeV
electron beams. The results were then compared to a number of cylindrical
ionisation chamber (Farmer and Wellhoefer CC13), PTW Markus chamber,
gafchromic EBT3 film, MOSkin detector, and MP512-Bulk detector. The
MP512-EPI had excellent full dosimetric characterisation and very stable
response for a high irradiation gamma dose of 60 kGy with a sensitivity
degradation of 0.3%/10 kGy.
The ability of MP512-EPI to measure 2D dose distributions was evaluated
using small IMRT and VMAT fields and a combination of homogeneous and
inhomogeneous insertions and a CMRP cylindrical phantom, and then
compared to EBT3 dose measurements and treatment planning system (TPS)
dose calculations. A Pinnacle3 version 14 TPS was used to optimise and
calculate all the plans using an adaptive convolution superposition algorithm.
A comparison of the dose distribution measured by MP512-EPI, EBT3 film
and TPS dose calculation in a homogeneous phantom revealed a gamma pass
rate of 97.11%±1.62 (1SD) and 99.72%±0.55 (1SD) for 2% /2 mm and
3%/3mm criteria for all plans. The similar results demonstrated in the
heterogeneous phantom, a reconstructed MP512-EPI dose compared to EBT3
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film and TPS dose calculation revealed a gamma pass rate of 97.58%±1.07
(1SD) and 99.60%±0.41 (1SD) for 2%/2mm and 3%/3mm criteria,
respectively. Whereas the reconstructed MP512-EPI doses compared to the
measured EBT3 films dose and TPS dose calculation revealed a gamma pass
rate of less than 85% for criteria of 1%1 mm for both phantoms. The
reconstructed MP512-EPI doses at smaller gantry angular increments showed
slightly improved passing rate criteria of 2%/2mm for gamma and a VMAT
plan delivery within ±2% (1SD).
This MP512-EPI detector will be used for 3D dose reconstruction in
conjunction with rotating phantoms and it will be evaluated in terms of 3D
gamma analysis and dose volume histogram (DVH). Future work will be
devoted to the development of a Quadro MP512-EPI detector with four tiled
MP512-EPI that will enable a sensitive area of 10×10 cm2 to maintain the same
spatial and temporal resolutions.
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Chapter 1
Introduction

1.1 Introduction
Since external beam radiation therapy (EBRT) is now an effective option in cancer
treatment, new equipment and techniques have been developed to provide high quality
therapy. The treatment must deliver the highest conformal dose to a tumour while sparing
healthy tissue; the methods used to minimise complications are stereotactic localisation
techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy
(SBRT) or stereotactic ablative radiotherapy (SABR). While stereotactic radiation
therapy provides much better radiobiological effectiveness than conventional photon
therapies [1]. This technique is so complex that quality assurance devices are becoming
more of an issue. More than 150 accidents with stereotactic radiotherapy have been
reported, of which almost 62% stemmed from the quality assurance (QA) process [2][3].
The complicated treatment field due to a small field size and intensity modulated
dosimetry means that point dose measurement cannot verify pre-treatment plans, and
therefore planar dose (2D) and three-dimensional (3D) dosimetry is needed to verify the
full plan delivery, including the penumbra or low dose region. Moreover, QA devices
require small active volumes with high spatial resolution, water equivalence, dose rate
and energy independence, and linear dose responses to achieve sufficient accuracy [4].
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This thesis focuses on the development and characterisation of a two-dimensional (2D)
monolithic diode array MagicPlate-512 that is based on epitaxial silicon; it is an efficient
and accurate quality assurance tool for small field intensity modulated radiotherapy.

1.2 Objective of the study
The objective is to examine the feasibility of using a 2D monolithic detector array
(MP512) based on epitaxial (MP512-EPI) and bulk (MP512-Bulk) silicon substrate as a
2D and 3D QA dosimeter for small field dosimetry in SRS and SBRT. The detector arrays
were designed and developed by the Centre for Medical Radiation Physics (CMRP) at
the University of Wollongong. For this purpose the full characterisation of a 2D
monolithic detector array (MP512-EPI) and the small IMRT and VMAT plans were
highlighted and validated. The parameters measured with MP512 were investigated and
extended for use with an adaptive 3D dose reconstruction to verify it for patient pretreatment.

1.3 Outline of the thesis
The general background and project goals are introduced in Chapter 1 while Chapter 2
describes and summarises the literature review of small field dosimetry. This review
focused on stereotactic body radiotherapy (SBRT), the technique used to locate tumours,
SBRT equipment, and a critique of QA in small fields. This chapter also discusses the
benefits and drawbacks of current QA tools. Chapter 3 focuses on the intrinsic
directional dependence of 2D monolithic diode arrays based on a bulk silicon substrate
( MP512- Bulk) . It also studies the effects that photon energy and field sizes have on the
angular response; the various field sizes were delivered using 6 MV and 10 MV photon
2
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beams. This chapter also introduces a developing angular correction factor to improve the
accuracy of MP512 measurements, and its verification procedures using the small static
fields employed in SRS and SBRT.

Chapter 4 explores the full dosimetric

characterisation of MP512-EPI for external radiotherapy using a Varian Clinac iX (linear
accelerator). Characterization is studied in terms of radiation hardness, percentage depth
dose (PDD), dose rate (MU/min) dependence, the dose per pulse response, dose linearity,
as well as the angular response and segmental dose linearity. This chapter also presents
an electrical characterization of IV characteristics of detector before and after irradiation.
Chapter 5 explores the validation of using MP512-EPI for quality assurance in an SBRT
plan in combination with a cylindrical PMMA phantom developed by the Centre for
Medical Radiation Physics ( CMRP) , at the University of Wollongong. Patient pretreatment verifications for homogeneous and heterogeneous phantoms were examined for
IMRT and VMAT. The MP512-EPI measurements were reconstructed using the angular
correction factor to mitigate the effect of angular dependence before comparing it to
EBT3 film dose measurements and TPS dose calculation. This chapter also examines how
the treatment couch influences the patient dose verification where an actual gantry was
performed. Chapter 6 describes a method for reconstructing a 3D dose to verify patient
pre- treatment using companies with 2D monolithic arrays and cylindrical PMMA
phantoms. The MP512- EPI measured the significant parameters using a 3D algorithm
such as the off-axis ratio (OAR), and the PDD and tissue maximum ratio (TMR). Chapter
7 summarises the study outcomes, including the advantages and disadvantages of the
MP512 detector.
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Literature Review

Since external beam radiation therapy (EBRT) is now an effective option for treating
cancer, new equipment and techniques have been developed to provide high quality
treatment for patients. It is desirable that the treatment method can deliver the highest
conformal dose to a tumour while sparing normal tissue and minimising complications.
Over the past decade, stereotactic radiosurgery (SRS) and stereotactic body radiotherapy
(SBRT), or stereotactic ablative radiotherapy (SABR) has been increasingly used in the
field of external radiation field because they are much better than conventional external
beam therapy.
This chapter focuses on SBRT/SABR because it is used for small field dosimetry
and this technique requires effective quality assurance (QA). There is also a discussion
of current QA tools and their limitations, as well as the problem of small field dosimetric
verification.

2.1. Stereotactic Body Radiotherapy (SBRT) /SABR
2.1.1. Overview
Stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR) is
defined by the American Society of Therapeutic Radiology and Oncology (ASTRO) as
an external beam radiation therapy method for delivering very precise high dose radiation
per fraction to an extracranial tumour target, using one to five fractions [5]. Since the
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SBRT target has a small margin, the prescribed dose is specified at an approximately 80%
isodose lower than a conventional technique, while the heterogeneous dose and hot spots
within PTV have been accepted under clinical consideration [6]. In a fractionated
regimen, SBRT/SABR offers better outcomes in terms of a biologically effective dose
(BED) relative to conventional external beam radiotherapy [1], and whereas a
conventional technique delivers doses of 1.8 to 2.0 Gy per fraction and total doses of 6070 Gy, SBRT applies a lower dosage using a hypo-fractionated scheme of five or less
fractions between 10 to 20 Gy per fraction. Moreover, the small number of radiation
fractions make SBRT more comfortable and convenient for the cancer patient.
The general concept of SBRT was developed from single fraction intracranial
radiosurgery. In 1951, Lars Leksell [7] introduced the term radiosurgery where he
delivered a single high dose fraction to a small intracranial lesion using a rigid metal
frame for localised targets. The extracranial stereotactic frame and three-dimensional
coordinate system for spinal lesion was developed by Hamilton et al. in 1995 [8]. This
technique works on the principle of a rigid immobilisation of the brain by screwing a
frame to the spinous processes, and although it is accurate within 2 mm, it is also time
consuming and inconvenient. At the same time, Lax et al. constructed a stereotactic body
frame with a vacuum bag that immobilises the body from caudal to tarsal with noninvasive patient fixations [9]. The author found that patients could be placed in the same
position within 5-8 mm. Since body lesions are more complicated and difficult to
irradiate than brain lesions due to organ movement, extracranial lesions can be displaced
during and between fractions of irradiation by internal organ motions such as breathing,
gastrointestinal peristalsis, and cardiac contraction. This means that the relative position
of a tumour and the external marker is not reliable enough to ensure accurate radiation,
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which is why improved image-guidance and software are crucial to allow for accurate
delivery of SBRT.
Treatment machines have recently been improved with a collimator that provides more
accurate dose conformation for stereotactic plans and very efficient image-guidance for
more accurate localisation. This technology has led to increased confidence in
implementing SBRT in multi-centres around the world. In fact SBRT is now an effective
treatment for curative and palliative indications [2][10], with the three most frequent sites
for treatment being spine, lung, and liver.
2.1.1.1. SBRT for spinal tumours
Spinal SBRT is a more challenging technique than traditional external beam radiation
because it delivers a higher dose of radiation to spinal tumours without exceeding the
cord tolerance. The spinal cord is a critical organ for spine irradiation because a high dose
of radiation to the spinal cord can induce myelitis [6]. The spinal cord dose is limited to
10 Gy in 10% of the spinal cord, defined as 6 mm maximum above and below a planned
target volume according to radiation therapy protocol oncology group number 0631
(RTOG0631) [7]. A typical regimen of conventional external beam therapy for spine
metastasis is 30 Gy in 10 fractions whereas radiosurgery irradiates with a target dose of
8 to 25 Gy in one to five fractions [8]. The selected dose per fraction depends on factors
such as the dimension and location of lesions, a patient’s histological status, previous
treatment, and which device is available. Tumour(s) on the spine are either extradural
(vertebra bodies or in paraspinous regions) or intradural (extramedullary or
intramedullary) [2], most of which are spinal metastases (up to 40%) that commonly
occur at vertebral bodies in about 35% of cases [9][10]. Radiosurgery for spinal
metastases is focused on the reduction of pain, improving sensory and motor function,
and controlling the growth rate of local tumours [10].
6
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2.1.1.2. SBRT for lung tumours
Lung SBRT/SABR is treatment offered to patients who are high-risk for surgery due to
the location or size of the tumour(s) and their health. Lung SBRT is commonly used for
early stage non-small cell lung cancer (NSCLC), oligometastasis, and the early stage of
small cell lung cancer [13][14]. The single biggest problem with treating lungs is
respiratory motion where tumours can move from 3-5 cm [15]; respiratory motion
therefore limits the treatment outcomes due to the intra-fraction motion due to errors
generated acquiring the images, planning the treatment, and delivering the radiation. The
effects of respiratory motion can be minimised using a vacuum bag to immobilise and
limit abdominal compression and movement, by respiratory gating to treat each specific
respiratory phase or track the tumour in real time with MLC tracking as the tumour moves
[16][17]. 4D CT scanning is proving to be a major technique for accurately delineating a
tumour using physiologic movement for a specific phase of the respiratory cycle [18].
Treatment with lung SBRT is normally carried out with a non-opposing beam, with noncoplanar multiple beams (7-11 beams) or a combination of arc delivery and online imageguided radiation therapy (IGRT) to accurately locate the position of a tumour. The dose
delivery limit to a lung with a volume of 10% (V10) is less than 20 Gy of the total dose of
60 Gy (20 Gy/Fx) following the RTOG protocol number 0236, 0813 and 0631 [19] [20].
2.1.1.3. SBRT for liver tumours
The common SBRTs used for livers are primary hepatocellular carcinoma (HCC) and
liver metastases [1]. SBRT is primarily used to maintain the systemic cytoreduction
response of a liver as well providing systemic therapy to reduce the tumor without
resorting to surgery. The margin of gross tumor volume (GTV) plus up to 5 mm for radial
and 10 mm for the superior-inferior can be treated as the planning target volume (PTV),
where the normal dose delivery is 14-26 Gy for one fraction or 30-36 Gy in three fractions
7
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[21][22]. The VMAT or non-coplanar multiple static beams delivered using photon
energies of up to 15 MV depends on the size of the patient’s body. The dose used to treat
liver cancer that a patient can tolerate is based on the dose a normal liver can receive, so
the accumulated dose must less than 15 Gy (an overall treatment dose) for a liver with a
volume 700 mL. To reduce respiratory motion and target the liver precisely, SBRT
delivery must utilise custom body immobilisation with radiopaque markers or combine
with 3-5 gold fiducials implanted around or within the tumour tissue. Moreover,
respiratory motion can be minimised by abdominal compression, breath holding
techniques, and respiratory gating.

2.1.2. SBRT equipment
There are at present many commercial delivery treatments which can deliver a steep dose
gradient to a tumour lesion while sparing the critical organ; they include a compact
imaging system that provides extreme accuracy and precision for localised targets. These
treatment delivery methods are classified into three groups (2.1.2.1, 2.1.2.2, and 2.1.2.3,
below), according to the capability of the image and delivery application system [23].
2.1.2.1. Irradiation with micro-stationary fields by cylindrical collimator
Stereotactic radiation is delivered with a micro cylindrical collimator and a robotic system
(CyberKnife®, Accuray, Inc., CA, USA) (Figure 2.1). A 6 MV linear accelerator is
mounted on a robotic arm that can rotate with six degrees of freedom, and the delivery
system and verification of the set-up position for the patient operates through two
orthogonal kV images and two 3D camera arrays [24]. The circular fields can emit noncoplanar and non-isocentric beams at large angles around the patient, this enables high
doses to be delivered directly onto a target while avoiding normal tissue; the average
delivery per plan is 100-300 beams [25]. To treat a target at an accurate sub-millimetre
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level, a specialised tracking systems such as XsightTM spinal tracking, SynchronyTM, and
XsightTM Lung are used [26].

Figure 2.1: CyberKnife Treatment components [27].

2.1.2.2. Irradiation with stationary fields shaped by a multileaf collimator (MLC) with
gantry-based systems
The most common equipment used to deliver radiation for stereotactic tumours are linear
accelerators (LINAC) with intensity-modulated radiation. This machine normally uses a
2.5 mm to 5 mm leaf-width MLC attached to a conventional LINAC such as ClinacIX
(Varian Medical System, CA, USA) and Elekta (Stockholm, Sweden). While a LINAC
such as the Novalis system (BrainLAB, Inc., Munich, Germany) can be dedicated with a
built-in micromultileaf (Figure 2.2), all treatment machines are equipped with imageguidance to verify pre-treatment targets, where the image information can originate from
an orthogonal x-ray or a cone beam CT. These treatment machines deliver a series of
small segment radiation or sub-beams by modulated intensity photon fluence by changing
the shape and speed of the MLC to produce a steep dose reduction at the targets. This
delivery technique is known as Intensity Modulated radiotherapy (IMRT), and with
SBRT, a patient is usually treated with four to twelve IMRT beams [28][13][29].
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(a)

(b)

Figure 2.2: Gantry- based systems ( a) Novalis machine [ 30] and ( b) Built in micro
multileaf [31].

2.1.2.3. Irradiation with a circular approach from a moving source or table (Arc
treatment)
Arc treatment is a delivery radiation system where a circular method is used to rotate the
source (linear accelerators base) or move the table (TomoTherapy Hi-Art System).
Volumetric Modulated Arc Therapy (VMAT) is a common technique that delivers a dose
to patients with a rotating gantry of linear accelerators (LINAC) such as RapidArc®
(Varian Medical Systems, CA, USA) that surrounds a patient’s body with a stable couch.
The dose is modulated by changing the speed of the gantry, and the dose rate and multileaf
(MLC) shapes, while the gantry is rotating [32][33]. The colours of the dose washes for
the IMRT and VMAT plans for SBRT are shown in Figure 2.3.
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Figure 2.3: Colours of dose washes for IMRT and VMAT plans for pulmonary SBRT
using LINAC base [33].
Tomotherapy Hi-ART (TomoTherapy, Inc., Madison, WI) is a CT-based delivery
technology that can provide information from megavoltage computed tomography
(MVCT) images. This imaging system enables high set up accuracy and will determine
and correct patient position before delivering radiation; it can also modulate the intensity
of the dose distribution via a binary multileaf (MLC) mounted on a slip-ring gantry
(Figure 2.4). A helical fan beam emits radiation at 3600 around a patient with a source to
axis distance (SAD) of 85 cm, while the table moves into the gantry in a superior-inferior
position and the selected pitch depends on the size of the target [34][35]. The precise table
index and movement have a significant effect on the accuracy of the dose delivered.
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Figure

2.4:

A

schematic

configuration

for

Tomotherapy systems [36].

2.2. Critique of QA
SBRT delivers a very high dose per fraction and provides a steep dose gradient in a small
field which usually places the margin of the boundary tumours in close proximity to the
organ at risk (OAR). Therefore, this technique requires effective quality assurance in the
overall process, from patient immobilisation, target delineation, the treatment planning
system (TPS), and throughout delivery. The American Association of Physicists in
Medicine (AAPM) has given practical guidelines (task group 101: TG101) for SBRT
quality assurance procedures for medical physicists, oncologists, and therapists [6]. There
are two primary dosimetric verifications in the entire quality control of small field
delivery treatment; the first part is the accuracy of beam data measurement used for
calculating and optimising the dose distribution such as the percentage depth dose (PDD),
the tissue maximum ratio (TMR), output factors, and the off-axis ratio (OAR); the second
is a patient-specific quality assurance phase that verifies the accuracy of dose distribution
from the planning system to the dose delivered to patients.
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2.2.1. Small field: Overview and definition of field size
The charge particle equilibrium (CPE) is where the number and energies of photons or
particles entering a volume of interest are the same as those leaving the volume. A CPE
is a significant situation condition used in conventional dosimetry, according to Technical
report series No.938 and ICRU 1980 [37]. The most critical issue of small field dosimetry
is a lack of CPE where the dimensions of the collimator field are less than the lateral
range of secondary electrons and the source of partial radiation is obscured by the
collimator. Variations in the range of secondary electrons depends on the photon energy
and spectrum because the electron range increases as the photon energy increases; the
approximate range of secondary electrons for a 6 MV photon beam is normally 16 mm
[38]. Moreover, the density and composition of the medium have a significant impact on
the penumbra and effective beam size, and the range of electrons in a low density medium
such as air is longer than the range of electrons in water [39]. This phenomenon can be
defined as a small field where the dimensions of the beam are smaller than the range of
secondary or charge particles at the central axis of radiation beam [40]. According to these
theoretical and clinical data measurements, fields that are smaller than 4×4 cm2 are small
field sizes whereas conventional fields are defined with sizes ranging from 4×4 cm2 to
40×40 cm2 [38]. Figure 2.5 shows the effect of overlapping penumbra on the full width
of half maximum (FWHM) achieve form small field collimator setting [38].
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Figure 2.5: The effect of penumbra overlapping on the full width of half
maximum (FWHM) achieve from small field collimator setting [38].

2.2.2. Detector size, spatial resolution, and density
The use of small fields in stereotactic radiosurgery combined with intensity-modulated
delivery creates a challenging scenario for accurate dosimetry because the two most
significant concerns for small field dosimetry are the averaging effects of detector volume
and the spatial resolution of detectors [41] [42]. Laub W.U. et al. found a significant
difference in the absolute dose measurements when using the different size detectors for
IMRT fields; they were up to 6% between a 0.6 cm3 Farmer chamber and a 0.015 cm3
pinpoint chamber. The same results appeared in other reports, where a drop in the output
factors for small field occurred in a central beam due to a partial source combined with
electronic disequilibrium and decreasing scatter. These effects caused the under response
signal of the detector to respond and a blurred penumbra due to a too large detector
(Figure 2.6) [42][4][43]. Inaccurate output factors and broadened penumbra
measurements are basic parameters for a treatment planning system, so inaccurate
monitor unit calculations and planning optimisation resulted in an incorrect dose being
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delivered to a patient [43][44]. To avoid the effects of volume a detector should be small
enough to measure the uniform dose region of a small field, therefore its maximum size
should not be greater than half the full width of half the maximum (FWHM) of the beam
profile, and furthermore, the spatial resolution of the device should be the same size as
the calculation grid used in the treatment planning system (less than or equal to 2 mm)
for end-to-end testing [6].

Figure 2.6: The volume averaging effect (a) a schematic diagram of a detector inside
a broad and narrow beam [ 38] ( b) a comparison of output factors and dose profiles
measured by various detectors [45].
The density perturbation effect stems from detector measurements in small field
dosimetry; it can be explained using Fano’s theorem that states the effect of particles
emitted per unit mass [46] is the difference in mass density compared to the influence of
water and the uniformity of the fluence of charged particles in the medium. A low-density
detector such as an ionisation chamber can produce fewer electrons than water, so
electrons with a longer range can exit the cavity and lead to a lower dose in the detector.
However, a detector of high Z material such as a diode emits higher number of secondary
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electrons in the detector than water material measurement due to a shorter electron range
where most electrons are absorbed in the medium and fewer in the exit cavity.

2.2.3. Ideal detector for small field dosimetry
Since small field dosimetry is complicated it is difficult to find a perfect detector. An
ideal detector for small field dosimetry should have the following attributes:
(i).

A stability response within 0.1 % for short-term measurements of large
doses and multiple beam irradiation, as well as long term stability that does
not require frequent recalibration.

(ii).

It should have a linear response to a clinical dose range of 1-1000 cGy.

(iii).

A stable response independent of dose-rate measurements because

treatment machines such as LINAC can change the dose rate (MU/min) during
VMAT delivery.
(iv).

Since the dose per pulse varies depending on the distance measured and

the medium, the detector should be stable when measuring in a typical dose
per pulse range of 0.2-0.4 mGy per pulse.
(v).

An ideal detector should respond to a wide photon energy range and not be
affected by attenuation of low energy photons and low electrons.

(vi).

Volume averaging by a large detector can cause penumbra boarding, so
small spatial resolutions are needed in small dosimetry where a high dose
gradient is presented.

(vii).

A high temporal resolution to accurately verify the time-resolved

dosimetry for 4D IMRT and VMAT delivery in combination with respiratory
gating or a tumour tracking system. A high temporal resolution detector can
reduce the burling effect of an integrated gantry and moving MLC.
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(viii). It should be water equivalent to avoid any extreme electron perturbation
from its composition and density due to the ratio of the mass energy absorption
coefficient and the stopping power of water and the detector medium.
(ix).

It should respond isotropic ally to the direction of the radiation beams

while the gantries rotate around the detector.
There is no ideal detector that IPEM could recommend other than the detector used to
measure in small dosimetry [47].

2.3. The quality assurance currently available and its
limitations
In recent years many commercial QA tools have been used in radiotherapy. The following
examples are devices currently available for measuring relative dose parameters such as
beam profiles, PDD, output factors including patient pre-treatment and in-vivo
verification. This section will give a general description of detectors including their
specific configurations, functions, and limitations. The detectors will be classified into
four categories based on their basic dose measurements.
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Table 2.1: A summary of dosimeters used for megavoltage photon beam dosimetry
Dosimeter

Applications

Advantages

Limitation

Ionisation chamber

Absolute and relative
dosimetry
measurement,
QA testing,
commissioning
measurement
(1D, 2D and semi-3D)

High level of accuracy
and reproducibility,
dose rate and energy
independence

Volume averaging
effect

Silicon diode

Relative and in-vivo
dosimetry
measurement
(1D, 2D and semi-3D)

High sensitivity and
good spatial resolution

Sensitive to low dose
(High Z), directional
dependence and
response sensitivity
depend on accumulated
dose

Diamond detector

Relative dosimetry
(1D)

High sensitivity and
spatial resolution,
tissue equivalent, less
dependence on dose
per pulse and dose rate

Cost expensive, high Z
of electrode increases
electron scattering

Scintillating fibre

Relative dosimetry
measurement,
intracavitary therapy
(1D)

High sensitivity and
spatial resolution,
tissue equivalent, wide
dose range
measurement, flexible

Cherenkov effect (high
noise within system)

Radiochromic films

Relative dosimetry
measurement (2D)

High sensitivity and
spatial resolution,
tissue equivalent,
energy and dose rate
independent and
directional independent

Not real-time read-out,
scanner system and
film batch dependent

Gel dosimeter

Relative dosimetry
measurements (1D, 2D
and 3D)

High sensitivity and
spatial resolution, near
tissue equivalent,
actual 3D dosimetry

Not real-time read-out
and sensitive to the
preparation (chemical
proportion) and readout procedure (image
artefact)

Flat panel electronic
portal imaging device
(EPID)

Relative dosimetry
measurements (2D and
semi-3D)

High sensitivity and
spatial resolution, dose
rate independent, no
extra phantom
requirement

High Z, signal is
nonlinear to dose
measurement, suffer
from radiation
backscatter (supporting
arm), ghosting and
image lag effect
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2.3.1. Point dose
2.3.1.1. Ionisation chamber
Ionisation chambers (IC) are commonly used in EBRT due to their directional
independence (cylindrical shape), dose linearity, dose rate and energy independence (kV
energy range), and sensitivity to stability [48][49]. An IC can measure an absolute or
relative dose, and it can verify output factors and point dose in the central axis of beams.
The major components of an IC are its air or liquid filled cavity and the chamber electrode
(anode and cathode). An IC measures the current in proportion to the electron-ion pair
generating from the interacting ionisation proceeding from the medium in the cavity. A
voltage must be supplied to the detector electrode to make the pairs of electron ions move
across the detector which created a current through the IC. The appropriate voltage
depends on the size of the chamber; this means a large chamber must supply up to 400
Volts. The numbers of electrons depend on the energy deposited within the volume (EX:
1 MeV produce 30000 ion pairs), the distance between electrodes, and the voltage supply
and the density of the detector (either gas or liquid). ICs come in various sizes as defined
by the average sensitive volume; a standard IC volume of 0.6 cm3 is generally used as a
reference chamber and an IC volume of 0.13- 0.14 cm3 is generally used for beam
scanning [50][37]. However, the volume averaging effect of a large IC can underestimate
the dose in the central and broadening penumbra in the steep dose region of a small field
[51][42].

To

minimise

this

effect,

the

PTW31016

PinPoint

(0.016

cm3),

Wellhofer/Scanditronix compact ionisation chamber, model CC01 (0.01 cm3) and CC04
(0.04 cm3), were introduced into radiosurgery and small field (Figure 2.7) [52][53]. The
preferred chamber size should be compromise between its sensitivity and its signal to
noise ratio response. Since CC01 and PinPoint have a small volume the anode is made
from a high-Z material to maintain appropriate signal to noise ratio so the response of
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both detectors depends mainly on the low energy photons [54]. Apart from which the
polarity, cable, and stem effects of small ICs is of more concern that an IC with a large
volume, particularly when they must perform in the regions of homogeneity or where the
dose across the detector is less than 5- 10% [48].

(a)

(b)

Figure 2.7: The ionisation chamber used in small field dosimetry: ( a) Pinpoint
(PTW31013)[55] and (b) CC01 and CC04 (Wellhofer)[56].

2.3.1.2. Single-Point silicon diode
The p-n junctions are commonly used in a semiconductor detector because the built in
electrical field is greater than 103 V/cm and it can be operated in a passive mode (without
external bias supply) [57]. There are two types of diodes based on bulk silicon wafers, ntypes and p-types. A p-n junction is obtained by doping the opposite impure material onto
a silicon substrate, so a p-type is doped with boron and an n-type is doped with
phosphorus. The basic operating principals of a silicon diode are similar to those within
an ionisation chamber, where the electrometer detects the diode current emanating from
electron-hole pair diffusion. Radiation energy that exceeds 3.6 eV produces an electronhole pair within the silicon, while the excess minority carriers within the diffused lengths
of p-side (electrons) and n-side (holes) diffuse to the opposite side of the depleted region
(p-n junction) and are collected by the anode and cathode (Figure 2.8) [58]. A silicon
diode has a higher response per volume than other detectors, for instance, with the same
volume the sensitivity of a diode is approximately 18000 times greater than the ionisation
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chambers [59]. These characteristics of diodes enables detector to be manufactured in
sizes less than 3 mm, such as SFD stereotactic, and PFD photon (IBA Dosimetry), both
of which have a diameter with an active area of 0.6 mm and 2 mm, respectively [56]. The
diode used in small field dosimetry is shown in Figure 2.8. While diodes are generally
used in relative dosimetry such as scanning beam profiles, depth doses, and measuring
MLC penumbra, they can perform within phantom or in-vivo dosimetry such as MOSkin,
which is one type of Metal Oxide semiconductor field-effect transistors (MOSFET).
MOSkin was designed by CMRP and using drop in technology for MOSFET chip
packaging in a tissue equivalent kapton tail making MOSkin suitable for small field
dosimetry, especially measuring surface doses in real time at water equivalent depth
(WED) 0.07mm [60]. However, silicon diodes should not be used for measurements of
absolute dose because while their response is almost MeV photon energy range
independent , their sensitivity increases if low energy photons are present due to their
high atomic number; these diodes still induce a perturbation effect and provide directional
dependence due to their high-Z material and asymmetrical orientation of the sensitive
volume [61]. The sensitivity of a diode also depends on the accumulated dose, and the
temperature and dose rate [62][63][64][65].

(a)

(b)

Figure 2.8: A schematic of p- n junction of silicon diode and the commercial p- type
silicon diode detectors for use in small field dosimetry (IBA Dosimetry) [56][58].
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2.3.1.3. Diamond Detector
A diamond detector is an outstanding QA detector for small field dosimetry because its
atomic number is almost tissue equivalent to Z = 6 (Zeff of tissue approximately 7.42)
[66][67], and it has a small sensitive volume ranging from 0.004 to 6 mm3 that provides
an excellent high spatial resolution suitable for measuring in the penumbra region of small
fields. Traditionally, a diamond detector uses a naturally grown diamond plate or dice
with a specific contact system embeds in a cylindrical PMMA capsule which made a
detector difficult to reproduce in the same sensitive volume. Recently, the synthetic
diamond detector has been developed based on chemical vapour deposition (CVD) by
embedding the CVD intrinsic layer on a highly conductive boron-dropped CVD diamond
film and grown on high-pressure high temperature single crystal substrate (HPHT) [68],
[69]. A diamond detector can also act like an ionisation chamber (TM60003 diamond)
or as a solid state diode (T60019 microDiamond) (Figure 2.9) [55][70] because its basic
operating principles are similar to an ionisation chamber and a diode detector. Similar to
silicon diode ionizing radiation interact with the diamond to create electron-hole pairs
which migrate towards the anode and cathode respectively and generate a signal current
that is measured by the electrometer. A microDiamond detector is a synthetic single
crystal which operating in the photovoltaic regime that can be operated at zero voltage so
no external voltage is required. These detectors are almost independent on energy of
photon beams because they provide a constant of the mass stopping power detector to
water ratio [71]. Diamond detectors will also indicate radiation hardness and long term
stability, as well as directional and temperature independence; they also less dependent
on varying the dose per pulse and the dose rate (MU/min) [72][73]. A micro-Diamond
can also measure an insignificant signal variation of absolute dose to water when
measuring a large field size of 40×40 cm2 or a small field size of 0.5×0.5 cm2 [74]. These
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advantages mean that a diamond detector can be used in PDD, output factors, and
measuring beam profiles for conventional and small field sizes (SRS and SBRT fields) in
all photon energy ranges, including electron energy [75]–[77]. However, diamond
detectors are is more expensive than diode and ionisation chamber detectors. The
composition and density of detector material such as the high-Z of an electrode or silver
conductive glue increases electron scattering so the dose absorbed by the detector’s
sensitive volume also increases [66].

(a)

(b)

Figure 2.9: A single crystal diamond detector ( SCDD) and its configuration ( PTWFreiburg) [78].

2.3.1.4. Single Scintillating fibre
Scintillation detectors have been developed and used in radiotherapy for past 15 years.
Common scintillation dosimeters using in radiotherapy are organic scintillators; they have
a low atomic number and are almost tissue-equivalent to plastic scintillators [79][80].
When irradiated photons or particles interact with the scintillating medium they stimulate
atoms into excited states and fall back to a ground state emitting photons into visible light.
The transfer of light through fibre optic is collected and converted into an electronic signal
by a photodetector [81]. Scintillators can read signals in real-time and have a linear
response to a broad dose range of photon and electron energy. The fibres in a scintillator
are flexible and small enough to enable it to measure a dose in intra-cavitary
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brachytherapy and intra-operative therapy. Scintillators have a high spatial resolution
(approximately 1 mm diameter), there is less degradation of the radiation dose and dose
rate, and they are energy and temperature independent [79], [80]. However, Cherenkov
in the fibre guide is the significant effect of inducing noise within the system [82], and
scintillators that combine with a silicon photomultiplier (SiPM) tend to show a higher
noise [83].

2.3.2. 1D array dosimetry
A point dose detector cannot distribute the entire planned dose or the beam profile in a
single irradiation, which is why a 1D array is usually based on an ionisation chamber or
diodes which fabricate the detector in a linear direction such as CA 24 scanditronix
Welhofer and an LDA-99 that provide a resolution of 2 cm and 0.5 cm, respectively. 1D
arrays are generally used for data commissioning and measuring a dynamic wedge
[84][85]. In 2010, Wong et al. introduced an innovative 1D diode array called a Dose
Magnifying Glass (DMG), which implanted 128 phosphor n+ on a p-type silicon wafer
with a high spatial resolution of 0.2 mm; this detector array was designed by CMRP for
use as a QA verification tool in SRT delivery [86].

2.3.3. 2D dosimetry
Point dose verification is no longer adequate for stereotactic RT once the beam shape has
been modulated, particularly for delivering a high conformal dose. 2D dosimetry was
developed to evaluate the full dose distribution measurement for IMRT and VMAT plans
dose delivery. There are several 2D detectors available, such as radiochromic film, IC,
and silicon diode arrays with EPID.

24

Chapter 2: Literature Review

2.3.3.1. Film dosimetry
The film dosimetry process is based on changing its optical density (OD), which is
proportional to the dose of irradiation that interacts with the film. The scanner measures
the dose using the light transmitted through the darkening films. Silver halide (AgH) film
or radiographic film was the first type of film dosimetry used to verify a relative dose in
the megavoltage energy range. Radiographic films have successfully validated twodimensional IMRT dose distributions by providing a permanent two-dimensional dose
distribution mapping with a high spatial resolution. However, they have many drawbacks
due to their varying sensitivity within each batch of film batch, a film process that
produces chemical, and artefacts caused by the densitometer (scanner) [87][88]. The
emulsion of radiographic film is based on high Z material, response of which depends
mainly on low photon energy (<1MeV) [48]. In 1980, radiochromic films were introduced
and widely used for dosimetry in radiotherapy because film processing is not required
and they are almost tissue equivalent. Gafchromic EBT3 film is the last generation of
radiochromic film used in radiotherapy due to its high sensitivity for radiotherapy dose
between 0.01 and 8 Gy [89]. EBT3 films has a uniformly thin active layer that is
sandwiched between symmetrical thicknesses of matte polyester [90]. Gafchromic films
has become a standard tool for verifying small field dosimetry because their high spatial
resolution provides two-dimensional (2D) dose mapping with sub-millimetre accuracy,
and they are energy and dose rate independent, as well as angular independent and tissue
equivalent [91][92][93][94]. However, radiochromic films cannot be read out in real-time
because they require at least 24 hours to stabilise [90], and they are dependent on film
scanning orientation, scanner uniformity, and the temperature of scanner bed, and that
makes film dosimetry depend on the read-out procedure adopted [95]. In addition, the
accuracy also depend on the colour channels and scanner resolution [94], [96].
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Radiochromic films can be used for measuring relative dose distributions and the relative
outputs in a small field such as the stereotactic field (4 to 30 mm2) provide on a Novalis
Trilogy [96], [97]; they are not recommended for measuring an absolute dose and
verifying monitor unit outputs [98].
2.3.3.2. Array detectors
Detector arrays are increasingly used in patient-specific verification for delivering IMRT
and VMAT plans because they provide a two-dimensional dose distribution in real-time
and are easy to setup. The two main commercial detector arrays are, 1) an ionisation
chamber-based detector and 2) silicon diode based detector. Table 2.2 is a summary of
the current commercial detector arrays.
(i). Ionisation chamber (IC) array
Amerio et al. introduced the initial design of pixel-segmented ionisation chambers array
(PXC) for verifying 2D doses distributed in complex shaped field delivery [99][100]. This
device contains independent cylindrical ionisation chambers with sensitive volumes of
0.07 cm3, i.e., 1024 IC that cover a 24×24 cm2 area at 0.75 cm spacing between them.
This PXC has excellent long and short term stability, as well as integral dose
independence and linear to dose measurements. Moreover, the output factor measured by
this device agrees within 0.4 % compared to a Farmer IC; this detector array has evolved
into an ImRT MatriXX (IBA Dosimetry, Bartlett, TN), which uses a combination with
specific software. The ImRT MatriXX has fabricated 1020 parallel plate ionisation
chambers with volumes of 0.08 cm3 and pitches of 0.76 cm that cover an active area of
24×24 cm2 [101][102]. These detector arrays performed very well in terms of field size
and independent SSD distance for 6 MV and 18 MV photon beams, they also had good
long and short term reproducibility, and an independent dose rate between 0.02 to 20
Gy/min and dose linearity [103]. Although the detector arrays had a gamma passing rate
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of more than 95% for IMRT and VMAT plans with 3%/3mm criteria, their wide
resolution showed a large discrepancy in the penumbra region (20%-80%) of a 2×2 cm2
field that was greater than 1 mm, unlike the beam profiles measured with the CC03
ionisation chamber [102][101][104]. Moreover, this device requires a pre-irradiation dose
of up to 10 Gy and a 15 minute warm up before it can be used. Another commercial 2D
detector array base on an ionisation chamber was designed and developed by PTWFreiburg; the seven29 PTW model T10024 has 729 air-vented ionisation chambers, each
with a sensitive volume chamber 0.125 cm3 by 0.5 cm in diameter. These IC chambers
cover an active area of 27×27 cm2 and have a 1cm spacing between them [105][106].
These devices are less dependent on energy and dose rate for a given range of
radiotherapy energy, but they do have good long and short term reproducibility and
uniform sensitivity across the arrays. The arrays also have a good agreement between the
beam profiles and wedge-modulated field measurements, unlike results measured by an
ionisation chamber in water [106]. Although the seven29 PTW requires a pre-irradiation
dose of only 100 MU, it needs more time to warm up before being used and it cools down
quickly. Moreover, the large spacing of two adjacent chambers and its large diameter
limits the potential of the seven29 PTW for stereotactic radiotherapy or in a gradient with
a high steep dose. To mitigate its spatial resolution limitations PTW-Freiburg introduced
a higher sampling density within an array called Octavius 1500 (OD1500). This new
prototype has 1405 ionisation chambers, each of which has a sensitive volume of 0.058
cm3, arranged in a checkerboard pattern covering an area of 27×27 cm2 [107][108]. The
OD1500 was designed for a higher range of dose rates with a flattening filter free (FFF)
beam (up to 48 Gy/min) [108]. This detector arrays have a very stable signal without
needing pre-irradiation and have excellent dose linearity within ±1% for doses ranging
from 5 to 1000 MU. The increased spatial sampling frequency of this detector array
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occurs when two measurements of couch shifting 5 mm merge to show a high agreement
of dose distributions with a gamma passing rate up to 99.6% and 96.9% for 3%/3mm
criteria, compare with dose predicted by radiation treatment planning system (RTP) and
measured by film, respectively. Although the output factors of the OD1500 agreed with
a field size above 4×4 cm2 within 1%, compared to a Semiflex chamber (CC13) and Si
diode, the output factors measured for a small field showed more deviations from the
reference detectors [107]. To meet the standard required of detectors for small field
dosimetry in SRS and SBRT technique, PTW-Freiburg introduced the first liquid filled
ionisation chamber array called Octavius 1000SRS (T0036). This detector array has the
highest spatial resolution of 2.5 mm in the inner area of 5×5 cm2 and 5 mm in the outer
area [109]. The 1000 SRS detector has 977 liquid filled ionisation chambers with a small
sensitive volume of 0.003 cm3 and covers an area of 10×10 cm2. This detector has less
energy dependence, good dose sensitivity linearity, good long and short term stability and
reproducibility, and has excellent agreement when measuring the output factors in a small
field down to 1×1 cm2. The gamma passing rate agreement between the detector
measurement and TPS calculation for IMRT verification is approximately 95.2% for
3%/3mm criteria, but the liquid filled ionisation chambers depend mainly on the dose rate
and dose per pulse because of the high incidence of ion-pair recombination. The detector
array signal dropped more than 3.5% when measuring a dose per pulse that was less than
1.7×10-4 Gy/min, and the cross calibration procedure must consider the pressure and the
temperature applied.
(ii). Silicon diodes array
The MapCHECK (Sun nuclear crop, Melbourne, FL) is the first commercial of 2D array
base on arrays of silicon diodes. The first MapCHECK prototype was model 1175 with
445 n-type diodes fabricating with a resolution of 7.07 mm in the central area of 10x10
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cm2 and 14.14 mm close by [110]. The MapCHECK2 has improved by increasing the
number of diode to 1527 and maintaining a resolution of 7.07 mm over an area of 32×26
cm2 [111]. The n-type diode used to fabricate the detector array was designed to depend
less on accumulated dose of radiation and small intrinsic build-up of 0.1 gm/cm2 for
measuring surface doses [112]. MapCHECK2 is better at verifying IMRT than films, with
excellent gamma passing rates for 6 MV and 18 MV photon beams and allows it to
calibrate using absolute dose measurements [103][113]. However, detector arrays based
on silicon diodes still have a high dose per pulse and directional dependence [114], and
MapCHECK2’s wide resolution is not suitable for measuring the steep dose gradient of
small fields
Table 2.2: Specifications of a commercial 2D detector array [115][116][55].
Detector

Detector size

Detector

Resolution

Number

Active

type

(mm)

volume

(mm)

of

Field

detector

size(cm2)

(mm3)
MapCHECK2

n-type diode

0.8×0.8×0.03

0.0192

7.07

1527

32×26

Pixel

4.5 diameter ×

80

7.62

1020

24.4×24.4

ionisation

5height

5.0×5.0×5.0

125

10

729

27×27

4.4×4.4×3.0

58

7.1

1405

27×27

(cubic)

ImRT Matrixx

chamber
(disc shaped)
PTW seven29

Plane-parallel
ionisation
chamber
(cubic)

OCTAVIUS
1500

Plane-parallel
Ionisation
chamber
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OCTAVIUS
1000SRS

Liquid-filled

2.3×2.3×0.5

2.6

2.5 in central

ionisation

area of

chamber

5.5×5.5

(cubic)

cm2

977

10×10

5 mm outer
area

2.3.3.3. Flat panel Electronic Portal Imaging Device (EPID)
EPIDs were designed and developed to verify patient localisation in radiotherapy and
then analyse and store the images in a DICOM file format. However, their use as a dose
verification tool has expanded rapidly over the last decade so they now provide high
spatial and temporal resolution (approximately 0.7 mm and readout 10 frames/sec), a real
time 2D mapping image and accurate positioning perpendicular to beam irradiation while
being mounted and rotating on the gantry arm [117][118]. EPIDs are now used for pretreatment verification and measuring directly onto the EPIDs without a phantom or
patient, and in-vivo dosimetry using transit dosimetry and back projection. EPIDs can be
based on fluoroscopy (video based), matrix liquid filled ionisation

chambers and

amorphous silicon (a-Si) systems [119][120][121]. EPID dosimetry is where scintillation
is used to convert radiation dose to a signal. The radiation generates electrons within the
Cu plate which create a visible light in the phosphor screen which is then detected and
integrated into charge captures by the photodiode array implanted onto an a-Si panel. The
aSi-based systems such as aS500/ aS1000 (Varian system), iView GT (Elekta) and
OptiVue (Siemens) have become popular and are commonly used to verify portal doses
because a lower dose can be delivered per portal frame; moreover, their long term stability
and reproduction over two years, independent dose rate, spatial resolution and image
quality are much better than other EPIDs. However, the response relationship between
EPID signal and dose is nonlinear scale the correction factor for effects of the acquisition
process are need to be consider [122]. In addition, EPID signal to dose conversion must
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to be calibrated for the various field sizes, beam energies, and distances from a central
axis due to their high atomic number that increases the photoelectric effect that makes
EPID signal beam energy and field size dependent [123]. Furthermore, the doses
measured by EPIDs usually suffer from radiation backscatter due to its extra layers and
supporting arm. The inadequate accumulation of material above the detector layer also
indicates the lack of an electronic equivalent in the phosphor scintillator layer
[124][117][125]. This means the charge trapped within the detector layer has a significant
influence on the ghosting and image lag effect for EPIDs.

2.3.4. 3D dosimetry
The significant issue with measuring 2D dose distribution is interpreting the results
because although 2D dose measurement can ensure that the dose delivered to a patient is
the same as the dose from TPS calculation, the patient’s corrected isocentre and the MLC
positioning error means that the data is only provided at that particular plane of
measurement. Calculating the advanced algorithms of a treatment planning system create
a complicated delivery plan which then provide a large amount of sub-field and irregular
shapes. This then requires a method that can evaluate and verify a large number of dose
points in three- dimensional (3D) treatment volume. A 3D dose distribution such as dose
volume histograms (DVH) is needed for dose verification and clinical interpretation, so
this section will classified 3D dosimetry into three categories; actual 3D dosimetry which
will measure the dose in its entire volume; semi-3D dosimetry that will measure particular
dose points within a specially designed phantom, and then use the dose calculation
method to predict the dose for the entire volume; and virtual 3D dosimetry which will
calculate the dose using fluence measurements.

31

Chapter 2: Literature Review

2.3.3.1. Gel dosimetry
In recent years measuring the gel dose is the only one of actual 3D dosimetry. Gel
dosimetry was introduced in 1950 to verify clinical doses [126]. A gel dosimeter monitors
and analyses the chemical changes in the interaction between radiation and the chemical
chain using external quantitative readout such as Magnetic resonance imaging (MRI),
computed tomography (CT) and spectrophotometric. The first generation of gel
dosimeters was the Fricke solution based on bulk water, ferrous sulphate (Fe2+) and
gelatin or agarose [126][127]. Although Fricke gels are easy and convenient to prepare
and the results can be read soon after irradiation, the ion diffusion effect reduces the
spatial dose information through the gel [128] [129]. Polymer gels dosimeter (PAG) such
as bis acrylamide nitrogen and gelatin (BANG) is a tissue equivalent material developed
to reduce diffusion via an infusion of monomers and cross linked servants in a gelatin
matrix [130][131]. The free radicals of water radiolysis induce a chain polymerisation
reaction as the monomers are cross linked in proportion to the absorbed dose. The
polymer gels reveal that 3D dosimeters can provide permanent 3D dose distributions
within millimetres, while the liquid form can be manufactured in an irregular shape such
as an anatomical phantom; these gel dosimeters also deliver independent dose rates and
energy in a clinically relevant range [130][132]. PAG is limited by oxygen which inhibits
polymerisation [133]. The normoxic polymer gel dosimeter known as MAGIC gel is a
new PAG which contains oxygen scavengers in the gel matrix to mitigate oxygen
inhibition. In 2003, a new polymer gel dosimeter called PRESAGETM was introduced; it
is a plastic radiochromic dosimeter that is not affected by oxygen. It consists of
polyurethane, leuco-dye leucomalachite green (radiochromic components), hydroxyl
reactive polyol, and alkyl diisocyanate prepolymer [134], [135]. The changing optical
density inside the PRESAGETM dosimeter is suitable for readouts with an optical based
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scanner such as He-Ne laser-based and an optical-CT scanner [136]. Unfortunately gel
dosimetry is sensitive to the conditional preparation of gel matrices such as the chemical
compound rate (type and radical initiator concentration), the light and temperature, and
the amount of time needed to prepare a procedure and then read the results [137], [138].
Moreover, the imaging artefacts from the readout system (MRI or CT) such as image
distortion, and ring and streak artefacts are important factors in determining the accuracy
of the dose measurements [127].
2.3.3.2. Semi 3D dosimetry
Semi-3D dosimetry is where multiple point doses are measured using built-in detector
arrays in a cylindrical phantom such as ArcCHECK (helical shape) and Delta4 (crossplane array). As well as dose measurements using 2D detector arrays (seven29, 1000SRS,
OC1500) combined with rotating phantom such as OCTAVIUS 4D system (PTW), dose
measurements are combined with the specific dose calculation algorithm to create a 3D
dose volume. The following section is a commercial semi -3D dosimeter system.

(a)

(b)

(c)

Figure 2.10: The general shape detector within the phantom for a commercial semi3D dosimetry system

(i). ArcCHECK
ArcCHECK (Sun Nuclear Corp, Melbourne, FL) is the first semi-3D cylindrical phantom;
it has 1386 diode detectors in a helical pattern at 1 cm spacing on the surface around the
PMMA phantom with the equivalent depth of 3.3 g/cm3 [139][140][141]. Each active
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diode is 0.8×0.8 mm2 and the active area is 21 cm in diameter 21 cm long. This device
was designed to deliver dynamic volumetric treatment; it is a time-resolved measurement
that acquires real-time data for each gantry at 50 ms updates using a virtual inclinometer
algorithm. The semi-3D dose calculation of AcrCHECK is used in combination with
3DVH (Sun Nuclear) software where the 3D dose reconstruction is calculated by scaling
the radiation ray traced through the phantom using a particular point dose measurement
at the entrance and exit detector which is then renormalised using dose distribution
calculated from TPS. The ArcCHECK has field size dependence and an ionisation
chamber that compares the over-response when the field size is less than 10×10 cm2 and
under-response when the field size is larger due to its spiral configuration and the
thickness of the build-up above the detectors [141][142]. This means a field size
correction factor must be applied while interpreting the 3D dose distribution.
Furthermore, calculating the dose of the ArcCHECK system also requires angular
correction and background correction [143]. Although the ArcCHECK detector is
arranged in a spiral pattern to improve its special resolution, a beam eye view (BEV)
spacing of 1.12 cm at SAD 89.6 cm is too coarse to analyse a small field size and small
MLC offset [141]. Moreover, since the detectors are arranged into a spiral shape there is
no detector in the isocentric of the phantom result so the device can only measure the dose
near the surface and cannot detect the scattered dose.
(ii). Delta4®
The Delta4® (ScandiDose AB, Uppsala, Sweden) is a 3D phantom manufactured from
two orthogonal p-type diode arrays arranged in an asymmetrical “X” shape (+50° and 40°) within a PMMA cylindrical phantom with a diameter of 22 cm. Each active detector
is 0.1 cm in diameter, and the 1069 diodes are fabricated at 0.5 cm and 10 cm spacing in
the centre of 6×6 cm2 and the remaining area of 20×20 cm2, respectively [144][145]. This
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device can measure a continuous sampling of dose per pulse at approximately 3 ms pulse
separation and 3 ms pulse width; the data is then stored to synchronise with the linac
pulses using the inclinometer attached to the treatment gantry. Since there is no
measurement between pulses there is a high signal to noise ratio so the device can be
utilised for 4D treatment delivery and segment-by-segment analysis. The Delta4®
operated combination with Delta4DVH (ScandiDos) software calculates the dose
measurement at particular points into a semi-3D dose distribution. The 3D dose has
calculated the dose along the radiation ray path using the dose detected by two diode
detector arrays. The Delta4 has good short term reproducibility and stability, dose
linearity, dose rate and dose per pulse independence [144][146], but it does show a
different angular response to gantry angles of 0° up to ±5% at a parallel detector plane
angle [146]. To reduce measurement uncertainty due to fluctuating beam outputs and
density values, the Delta4 the field measurements must be calibrated daily before using it
for pre-treatment verification [147].
(iii). OCTAVIUS and 2D array
The OCTAVIUS 4D® system (PTW, Freiburg, Germany) is a rotating cylindrical
phantom 32 cm in diameter by 34.3 cm long and is combined with 2D arrays such as
seven29, 1000SRS and OC1500 [108]. It was designed to deliver a modulated arc by
eliminating the influence of angular dependence on the accuracy of QA; this phantom can
rotate with a full angular range of ±360° [148]. The 2D array is always measuring
perpendicular to each incident beam angle, the rotation of the phantom is synchronised
with the linac using the inclinometer attached to the treatment gantry. The OCTAVIUS
4D® is a stand-alone verification system which does not require information from the TPS
dose distribution for calculations. The 3D dose distribution was reconstructed using the
summary of doses along the ray trace in each plane and the dose measured at a particular
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angle and the PDD curves installed in the PTW Verisoft software [149][148]. Since the
calculation is based on PDD data implementation, the accuracy of the measurement is
sensitive to the source of the phantom distance.
Semi-3D dosimetry does not directly measure a 3D dose distribution of treatment
delivery and is therefore not allowed to be used as an in-vivo dosimeter. The accuracy of
3D dose reconstruction relies on the detector’s characteristics and depends on the
accuracy of the calculation algorithm which calculates the full 3D dose from the limited
point dose measured within the phantom. The system must be validated before being used
for the recommended pre-treatment verification. Moreover, the accuracy of the dose
calculation is associated with the efficiency of the inclinometer because it is also used to
store data and phantom movements; therefore this inclinometer must be validated before
being used.
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Table 2.3: Summary of commercial semi-3D dosimeter specifications [139][144][148].

ArcCHECK

Delta4

Detector

Detector

Detector

Detector

Number

arranging

spacing

Volume

size

of

(mm3)

(mm2)

detector

10 mm

0.19

0.64

1386

3DVH

5 mm in inner

0.39

0.78

1069

Delta4DVH

Spiral shape

Bi-planar

Software

(10×10 cm2)
10 mm in
peripheral

OCTAVIUS

2D plane

4D system

VeriSoft
Depend on 2D array combination
(the summary is shown in Table 2.1)

2.3.3.3. Virtual 3D dosimetry
Virtual 3D dosimetry does not measure dose delivery within the phantom volume or in a
patient; it uses beam fluence to measure before or after radiation beam entry to calculate
the 3D dose distribution, as shown in Figure 2.11. Dosimeters are generally attached to
the machine so they can rotate with the treatment gantry. This kind of dosimeter can
operate as either before or during treatment delivery.
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(a)

(b)

Figure 2.11: A detector used for patient verification during treatment; (a) downstream
of the patient, and (b) upstream of the patient.

(i). A portal dose EPID
Portal dosimetry using EPID is a type of virtual 3D dosimetry that uses the transit dose
measurement. EPID generally uses the portal image to do a QA by comparing it with the
image predicted from the TPS but this type of verification cannot interpret the actual
difference in dose between treatment delivery and TPS dose calculation. EPID measures
the dose transmitted through a patient and calculates the dose inside the volume using a
back projection algorithm and the iterative method [150][151]. Commercial software
EPIdoseTM is designed for use in combination with conventional EPID; so the EPIDose
algorithm converts the EPID image into a dose by projecting the image to the simulated
dose plane or extended phantom (CT image), multiplies the output factor correction, and
then convolves the corrected EPID dose response with a redistribution kernel. A field
calibration map is then applied to the relative dose to reconstruct the 3D dose distribution
inside the volume [152].
Another virtual 3D dosimetry is where the entrance dose measurements use the
2D arrays dosimeter mounting on the treatment gantry head such as the COMPASS®
device, Dolphin detector, and the DAVID, and Delta4AT system. The photon fluence
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measurements are used in conjunction with a unique algorithm to derive the 3D dose
distribution within a patient’s volume.
(ii). COMPASS® system
The COMPASS® system (IBA Dosimetry, Germany) is an independent dose engine that
uses a collapsed con convolution/superposition algorithm in conjunction with 2D detector
arrays such as MatriXX, a novel pixel segment IC transmission detector (COMPASS
device) and wireless IC (Dolphin®) [153][154][155]. COMPASS arrays fabricate 1600
parallel ionisation chambers spaced 0.65 cm apart and with a sensitive volume of 0.02
cm3 [156]. Since this detector measures the fluence dose by being placed between the
radiation beam and the patient, the transmitted dose and surface dose is of concern. Sankar
et al. examined how the COMPASS device affected the dose surface and transmission
using 6 MV photon beams and found a significant difference in the dose at the surface
depth of 11.9%, with respect to the open beam measurement. However the dose
transmitted from the device had no effect on the depth beyond dmax in terms of the beam
profile and PDD curves, and showed a mean transmission factor of 0.967 for field sizes
ranging from 3×3 cm2 to 20×20 cm2. Similar results were found in the pixel-segmented
IC detector array Dolphin® transmission device (DTD). A DTD is a wireless device that
fabricates a small active area detector of 0.24×0.24 cm2 and 1513 air-vented ICs. It gives
a high resolution of 5 mm at the detector level (gantry head) and 8 mm at the beam
isocentre (SAD100 cm). It had a maximum surface dose of almost 11% at a 30×30 cm2
field and 80cm SSD. These results indicate that the influence of this device on the
transmission dose depends on its field size and the distance between the detector and the
surface. The surface dose decreased as the field size decreased and the SSD increased.
Furthermore, the device had less effect on PDDs beyond the maximum depth where
different doses were compared to an open beam of only 1% [157]. The DTD was a good
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agreement when used to verify the transmission mode during treatment for 2D and 3D
dose distribution compared to pre-treatment verification with MatriXX measurements
and TPS dose calculations [158]. Because the COMPASS® system is independent and
uses a complicated dose engine algorithm, it needs commissioning data such as beam
profiles, PDD curves, output factors, and absolute doses to model the calculation
algorithm [153].
(iii). DAVID system
The DAVID system (PTW) is an advanced real-time method of verifying modulated
treatment during delivery. This device consists of transparent multi-wire ionisation
chambers placed inside the accessory tray of the linac and aligned parallel to the MLC
leaf pair [159]; the number of wire chambers depends on the number of MLC leaf pairs.
The chambers are collected charge in a 2 mm thick volume of air and sandwiched by two
4 mm thick PMMA covers. This device monitors the shelf dose area product (DAP) with
an Integral Quality Monitor (IQM) [160][161]. Here, patient doses are monitored at each
MLC opening along the wire and the measured signal at each moment is determined the
length of the wire chamber not blocked by the leaf of MLC and integrated during
treatment delivery [162]. The total signal comes from the secondary electron and the
primary photon beam within the radiation field, with some secondary electron scattering
from the nearby chamber and background scattering from the linac head components. The
signal information is transferred to the control unit via a Bluetooth interface so it cannot
lose the signal due to its connecting cable problems [159]. The products from the dose
area is compared to the pre-recoded data. The presence of DAVID in the beam does not
interfere with the relative dose measured in the phantom, which showed insignificant
difference in the PDD curves with and without the device for 6 MV and 18 MV photon
beams. However, since the instrument is 14mm thick, the surface dose is enhanced by a
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factor of 1.13 and a transmission factor of 0.939 and 0.955 for the 6 MV and 10 MV
beams, respectively. Therefore, the transmission factor of the DAVID system is
considered to be a true factor that should be used to calculate the monitor unit (MU) for
all segments during the documentation process [163].
(iv). Delta4DT system
ScandiDos has developed an ultra-thin transmission detector called Delta4 Discover
(Delta4AT). It has 4040 p-type silicon diodes, each of which is 1 mm in diameter. The
detectors are arranged parallel to the MLC leaf pair trajectories (X direction) at 2.5 mm
spacing along the leaf and 5 mm spacing at the beam isocentre. The detector is fabricated
on a 0.5 mm PCB that relies on a 1.1 mm globe top embedded between two 0.3 mm thick
carbon fibres. This device has less attenuation and transmission factor closer to 1 and
provide less surface dose enhancement. It has an attenuation factor of 1% and the surface
dose only increases by 1 % for a 10×10 cm2 field. However, the scattering from the
collimator increased the surface dose by almost 9% when field was larger than 30×30
cm2. This device tracks MLC motion during treatment and also verifies the MU of each
segment. The Delta4AT has a built-in inclinometer that can verify the gantry and collimator
rotation, while the integrated laser can verify a patient’s position during beam delivery.
This device can analyse the 3D dose distribution in a patient by generating a virtual patient
dose using correlation of signal measured by transmission device with the Delta4 phantom
dose measurement [164][165].

2.4. Bulk Epitaxial Silicon diodes.
SBRT and SRS are complex radiotherapy treatments that involve multiple small segment
fields and angles irradiating around patients. These techniques require efficient 2D and 3
D dose verification with high spatial and temporal resolution. Although the ionisation
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chamber is used as a gold standard and practical radiation detector for external
radiotherapy, volume averaging has a significant effect in small field dosimetry. A silicon
diode is an outstanding candidate for use as an efficient dosimeter for sophisticated
radiotherapy delivery techniques, because their high sensitivity means they can be
manufactured to a small sensitive volume and still provide a good sensitivity and high
spatial resolution. As a consequence, CMRP has designed and developed several
spectacular silicon diode detectors based on p-type wafers that are used as a radiation
dosimeter. A p-type silicon diode was selected due to its superior characteristics
compared to n-type diodes in terms of linearity of the response with dose per pulse and
higher radiation hardness [166][167]. CMRP has developed various silicon detector
prototypes such as for surface point dose measurements (MOSkin), 1D diode array
(DMG), 1D orthogonal diode array (DUO) including 2D diode array (MP121 and
MP512) [60][86][168][169][170]. These detectors have been studied and are useful for
external beam radiation therapy dosimetry.
However, the silicon diodes exhibit angular, temperature, and dose per pulse dependence,
as well as being sensitive to accumulated radiation [171][57]. Marre et al. studied the
effect of an accumulated dose on several commercial diodes and found the detector lost
approximately 20-25% sensitivity at an accumulative dose of 1 Mrad for electron and
photon beams [172]. The degradation of sensitivity from radiation depends mainly on the
quality of radiation and the type of silicon [173][174]. Radiation can damage the mass
bulk and surface regions of silicon detector when energy that is greater than the threshold
energy is imparted, the point defects and clusters within the silicon lattice are created ;
this increases the leakage current, induces the growth of full depletion voltage and
degrades detector sensitivity. The effect of increasing of leakage current can be minimised
by using silicon diodes in a passive mode or no biased application [175].The sensitivity
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of silicon detectors is proportional to the active volume, and that depends on the area of
the detector (A) and the diffusion length (L). The diffusion length (L) depends on the
minority carrier time (τ) as shown by

= √

, where D is the diffusion constant. The

lifetime of the minority carrier will decrease the concentration of crystal defects increases;
these defects at a high and deep level create a recombination-generation (RG) centre
which reduces the lifetime of the minority carrier, decreases detector sensitivity, but
makes it more sensitive to dose per pulse and temperature [65][176][64]. An RG centre
can be managed using the oxygen doping technique or specific silicon growing
technology; with the silicon growing technique, the silicon substrate is doped with impure
material to modify the transport mechanism in the silicon lattice.
Brookhaven National Laboratories has developed oxygenated devices known as oxygenenriched floating zone (DOFZ) substrates where the oxygen is doped in the substrate to
form a vacancy-oxygen (V-O) complex in a deep level of the forbidden gap where the
energy is approximately 0.55 eV. This V-O complex resulted in the creation of the RG
centre. This technique is perfect for minimising the effect of radiation damage from
gamma irradiated by Co-60; it only creates point defects with no generating cluster
defects. However, the detector was still sensitive to degradation due to higher energy
irradiation. Besides, the process of manufacturing DOFZ makes is difficult to reproduce
the same macroscopic property and effective doping concentration [177], [178].The same
concept was used when doping n-type Czochralski silicon with platinum (Pt); Pt-doping
delivered a short diffusion range of charge carriers approximately 20 µm but this reduced
the sensitivity of detector in the low dose rate range [58].
In 2006, Lindstrom et al. studied the thin layer of low resistivity of an n-type silicon
detector using for tracking charged particles in hadron field and found its sensitivity had
improved [179]. The epitaxial layer is limited an active depth of detector which is shorter
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than the diffusion length and keep the active volume constant even after being irradiated
with high radiation. Santos et al. investigated the effect of clinical electrons with energy
ranging from 6 MeV to 21 MeV and photons with energy of 6 MV and 18 MV beams
onto the thin n-type epitaxial layer with a resistivity of 50 Ω cm, which had been grown
on 300 µm thick n-type silicon substrate. They found excellent characteristics in terms of
long and short term repeatability, electron PDD measurements, dose linearity for electron
and photon beams , and measurements of electron beam profiles, however the detector
also showed electron energy dependence and increasing current leakage current
[180][181]. Bruzzi et al. investigated the sensitivity of an epitaxial silicon detector to
radiation damage delivered from a Co-60 gamma source; they found that the n-type
silicon diodes decreased in sensitivity more than the p-type silicon diodes with an 83%
and 58% drop, respectively. Their study also showed the effect of epitaxial thickness and
guard ring distance to active area of the diode on radiation damage. A 50 µm thick
epitaxial layer provided high constancy and stability of sensitivity, with sensitivity
reduced by only 7% at a dose of 1.5 kGy and stability within 1.8% at 10 kGy. However,
the larger guard ring distance of 50 µm resulted in more stable sensitivity at a dose of 1.5
kGy [182]. These results mean that a p-type epitaxial silicon detector with a thin layer
and wide guard ring is better for a radiotherapy dosimeter, and moreover, p-type silicon
is not affected by changes in the absolute value of space charge by increases in fluence
[183]. Talamonti et al. investigated the first prototype of 2D arrays when the p-type
epitaxial layer was used as a dosimetric detector for pre-treatment verification [184]. The
prototype 2D detector arrays consisted of 21×21 pixels that achieved a resolution of 3
mm; this resulted in good dose linearity, excellent repeatability and reproducibility, as
well as less dependence on the dose rate. As a consequence, CMRP developed an IMRT
patient verification dosimeter based on the epitaxial p-type diodes with silicon epitaxial
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layer thickness of 50 µm and using drop-in technology for packaging of the diode called
magic plate 121 (MP121). An MP121 has 11×11 diodes with a sensitive volume of each
0.5×0.5×0.05 mm3 and 1 cm pitch. The sensitivity was stable within 2.1% after a preirradiation dose of 41.5 kGy and the excellent dosimetric characteristics for photon beam
irradiation remained. The detector showed good dose linearity and good agreement of
PDD measurements with CC13, ionisation chamber however the sensitivity of MP512
decreased as the dose per pulse increased [168]. However the 1 cm pitch of MP121 is too
coarse for use in small field dosimetry. Therefore, CMRP has designed a novel monolithic
detector fabricated on epitaxial p-type layer and providing a high spatial resolution of 2
mm they call MagicPlate512-epitaxial (MP512-EPI), it will be described and investigated
in this thesis.
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3.1. Introduction
This chapter focuses on the characterisation of the 2D monolithic p-type detector array
called MagicPlate-512 (MP512-Bulk) in terms of its intrinsic directional dependence and
the effects that energy and field size have on its angular response. This chapter also
presents a procedure for an angular correction factor development to improve the
accuracy of a dose map measured in a particular plane using small fields, as used in SBRT
and SRS.
This MP512-Bulk was designed and developed by the Centre for Medical
Radiation Physics (CMRP) to investigate dosimetric characteristics in terms of their
output factor, percentage depth dose, dose linearity and dose per pulse dependence, and
the uniformity of detector response by Aldosari et al. [170]. The beam profiles and
penumbra for field sizes less than 4×4 cm2 that are relevant to stereotactic radiation
therapy were measured and shown to be feasible for small field dosimetry. The Full Width
of Half Maximum (FWHM) of square radiation fields measured by the MP512-Bulk for
field sizes down to 1×1 cm2 matched within 2% compared to the gafchromic EBT3 film
data measurements [170], but the critical aspect of a silicon diode is its directional
dependence due to asymmetry in the detector packages and the high-Z material generates
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different attenuations of secondary electrons in different directions [185][186]. Variations
of detector response can be more than 10% due to anisotropy and detector assembly; the
results have been reported in several studies [70][187][188][189][190]. Paul et al.
examined the angular dependence of p-type semi-conductor surface diodes with an active
volume of 1.6×1.6×0.05 mm3 that were mounted on a 0.051 mm thick copper contact pad
of PCB. They showed that the detector varied in sensitivity between ±12% when
normalised to a normal incidence of the beam at a range of angles between ±45 degrees
[61]. The angular dependence of an n-type 2D diode array, MapCHECK (SunNuclear,
Melbourne, Florida, USA) was evaluated and compared with ionisation chambers, and a
maximum difference of almost 20% was found at the beam angle of 90 degrees [189].
Hosang et al. also investigated the angular dependence of a MapCHECK for verifying
RapidArc plans and found a significant difference in dose as large as 30.6±6.6% and
33.4±5.8% for field sizes of 10×10 cm2 and 3×3 cm2, respectively [190]. This
phenomenon affected the accuracy of angular dependence of the detector used in
rotational radiotherapy where many modulated irradiation fields surround the patient.

3.2. Material
3.2.1. MagicPlate-512 (MP512-Bulk) design and fabrication
The MP512-Bulk is a monolithic silicon detector array with 512 square diodes, an active
area of 0. 5×0. 5 mm2 and a pitch of 2 mm; it was fabricated by ion implantation onto a
470 m thick p-type silicon substrate (Figure 3.1). The MP512-Bulk is wire bonded to a
500 m thick fibreglass printed circuit board ( PCB) with plugs for connection to a fast
readout DAQ system. The detector and the wire bonding are covered by a thin layer of
protective epoxy for mechanical robustness. The MP512-Bulk was pre-irradiated with a
total water equivalent dose of 80 kGy from Co-60 gamma source to stabilise its response;
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the MP512-Bulk array operates in a passive mode where no bias voltage is applied to the
diodes.
The MP512-Bulk detector array was embedded between two 5 mm thick PMMA
slabs with an air gap above silicon pixels entrance surface. This packaging arrangement
(Figure 3.1b) is needed to protect the silicon detector and optimise the detector response
to small radiation fields by adjusting the air gap to match the detector’s response for small
radiation fields to radiochromic film [170], [191]. The air gap is 0.5 mm and 1.0 mm for
6 MV photon beam and 10 MV photon beam, respectively [192].

(a)

(b)

Figure 3.1: A schematic of the cross section of an MP512 detector component and its
packaging (not to scale).

3.2.2. Data acquisition system (DAQ)
The MP512 data acquisition system (DAQ) is based on a 64-channel analogue front-end
electrometer ASIC chip that provides an analog differential output that is proportional to
the charge that accumulates in a capacitor during a pre-selected time frame that is set
electronically through a software interface. The gain adopted in this work was set to span
a full scale range up to 9.6 pC max with a resolution of 16 bits and an integral linearity
of approximately 0.006% [193]. The baseline of each current integrator is subtracted
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using a double sampling approach: this feature is very important for maintaining accuracy
in a medical instrument which requires a high signal to noise ratio (Figure 3.2). Each chip
is interfaced to a quad analogue-to-digital converter (ADC), and the ADC output is
synchronised and the channels de-randomised by a field programmable gate array
(FPGA). The FPGA also synchronises the sync pulse of the LINAC to acquire a detector
current only when the electron gun injects electrons into the accelerator (for
approximately 3.7 µs every 2.7 ms at 600 MU/min on a Varian Clinac iX). The ADC
system can also acquire the detector array signal by an internal trigger generator with
frequency up to 10 kHz in case dosimetry on the source of isotopic radiation radiated
intensity in all directions.
The data is transferred from FPGA via USB2.0 to a host computer where the inhouse developed program interface (Magic Suite) operates. This program was designed
to perform real time signal processing where the signal from the detector is manipulated
immediately and the users can monitor in real time. Moreover, the Magic Suite interface
was designed to be convenient and easily accessible. The software enables a user to set
the acquisition parameters such as the integration time (µs) to match the detector, and the
acquisition length (s) and acquisition frequency (kHz) that synchronises with the radiation
time and machine, respectively. The program provides instantaneous and integral detector
response as an output, and this can be visualised using a map and histogram response
(Figure 3.3). The tool also provides an equalisation function that can be stored and
calculate the equalisation factor of the detector. Moreover, each acquisition parameter
and detector signal are recorded as log files that can be used for further offline analysis.
An overview of DAQ workflow is shown in Figure 3.4.
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(a)

(b)

Figure 3.2: The general operation schematic of ASIC ship (a) Dual switched integral
architecture and (b) Integration Timing [193].

(a)

(b)
Figure 3.3: Magic Suite interface (a) Map response display and (b) Histogram response
display.
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Figure 3.4: Flow chart of data acquisition (DAQ).

3.2.3. CMRP Cylindrical phantom
A CMRP cylindrical phantom is shown in Figure 3.5. It was built by CMRP using
polymethyl methacrylate (PMMA) material, also known as acrylic glass. The physical
density of PMMA is approximately 1.15-1.19 g/cm3 [194]. The phantom is a 30 cm
diameter by 40 cm long cylinder [170] , and has a central PMMA insertion slot of 15.5
×20.5 ×5 cm3, into which the detector array can be inserted.
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(a)

(b)

Figure 3.5: PMMA cylindrical phantom (a) Lateral view of phantom and (b) MP512
inside the phantom.

3.3. Methods
All the experiments in this chapter were carried out on a Varian Clinac iX (Varian
Medical System, Palo Alto, CA) at the Illawarra Cancer Centre (ICCC), Wollongong
hospital.

3.3.1. Equalisation and calibration factors
Before taking any measurements the MP512 must be equalised to correct for any sensitive
non-uniformity in the detector array and ASIC readout chips channels. This equalisation
factor was carried out by irradiating the MP512 using a 20×20 cm2 square field of 6 MV
photon beams and 200 MU. The detector was placed into water at a depth of 10 cm and
full scatter conditions by fixing the source to the isocentre of the detector (SAD) at 100
cm. This procedure has been investigated and used to obtain equalisation factors that were
calculated by following Equation (3.1) and (3.2) [168][170]. The equalisation coefficients
can be stored in the DAQ software interface.
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=

(3.1)
=

Where Fi is the correction factor vector, Xi is the pixel response,

(3.2)
is the average response

of detector and Xeq-1 is the equalized detector response.
Each pixel for the calibration factor was calibrated against a 0.6 cm3 Farmer
NE2571 ionisation chamber that refers to the relative calibration MU/min of the machine
[50]. The detector was set to a maximum depth of 1.5 cm for 6 MV photon beams with a
full back scatter of 10 cm solid water phantom and a fixed source to skin distance (SSD)
of 100 cm. A 10×10 cm2 field was irradiated to the detector delivering 100 MU and a
dose rate of 600 MU/min. The calibration factor for each pixel is defined by Equation
(3.3).

=

(3.3)

Where CFi is the calibration factor, DIC is the ionisation dose (cGy) measurement. The
detector was calibrated to 1 MU = 1 cGy and RMP512 is its response.

3.3.2. Angular response
The angular response is examined by inserting an MP512 into a CMRP cylindrical
phantom. The detector is in a vertical position and the treatment gantry is horizontal
(Figure 3.6). The central pixel of the detector array is aligned to the machine’s isocentre;
a 5×5 mm2 size field is used for fine alignment as the couch is moved in 1 mm steps
vertically and laterally to identify the maximum response of the central pixel. The
gantry’s horizontal position is defined as the zero incident beam angle because the beam
incidence is perpendicular to the detector surface. This setup enabled the angular response
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of the MP512 detector to be examined from 0 to +180 degrees without any interference
from the couch. The Linac gantry was rotated clockwise at 15° increments from the
incidence beam angle 0° to +180°. For a beam with a 10×10 cm2 field the gantry was
rotated at 1° increments for angles of incidence between 85° to 95° to finer characterise
the detector around the expected variations of maximum response. The MP512 was
irradiated five times with 100 MU for each angular position at a dose rate of 600 MU/min,
while keeping the central pixel at the isocentre (at a depth of 15 cm for PMMA and 85cm
for SSD). The square beams are defined by the primary collimators (jaws) field sizes of
1×1 cm2, 2×2 cm2, 3×3 cm2, 4×4 cm2 and 10×10 cm2. The relative angular response is
the ratio at which the pixel responds at a given angle of irradiation that is normalised to
the same pixel with a beam incidence of 0 degrees.

(a)

(b)

Figure 3.6: The experiment setup; (a) The MP512 embedded inside the phantom, (b)
Schematic diagram of angular response measurement (not to scale).

3.3.3. Gafchromic EBT3 film measurement
Gafchromic EBT3 film was used as the reference dosimeter to evaluate and correct the
angular response of MP512 by assuming that its response has no significant angular
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dependence. This EBT3 film was designed to minimise its angular response by using two
30 µm thick active layers stacked with two 125 µm thick matte polyester layers to protect
them from mechanical damage [195]; this configuration of EBT3 film is shown in Figure
3.7. The normalisation of the MP512 detector to EBT3 film response helps minimise the
mechanical tolerances as the LINAC gantry rotates around the phantom and the nonhomogeneous effects of the phantom.

Figure 3.7: The structure of gafchromic EBT3 film [195].
Films were calibrated by using 12 pieces from the same film lot, with each having areas
of 3×3 cm2 ; they were irradiated with 6 MV photons and an open 10×10 cm2 field at dmax
(1.5 cm) at SSD 100 cm that was placed on a 10 cm thick slab of solid water for back
scatter equilibrium. The films were exposed to doses from 0.25 Gy to 5 Gy, although one
film was retained to have its optical density baseline evaluated. A 0.6 cm3 farmer
ionisation chamber (model 2571) was used to measure the actual dose delivered for a
given MU setting under the same irradiation conditions. In this study, a Microtex
ScanMaker i800 was used for films scan procedure. Microtex ScanMarker model i800 is
the flatbed scanner with a staggered trilinear CCD array and a built-in transparency
adapter [196]. The set of calibration films were scanned six times at the same position in
the centre of a scanner with 48 bits of colour depth and spatial resolution of 72 dpi
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(equivalent to 350 µm size pixels). All the correction image parameters of the scanner
were set to disable. The last three scans were used to carry out the analysis needed to
ensure the scanner was thermally stable and the inter-scanning was consistent [89]. Data
analysis was carried out using the red channel which had been extracted using ImageJ
V1.48 (National Institute of Health, USA). The mean pixel values were calculated for a
region of interest (ROI) of 2×2 cm2 at the centre of each film patch to determine the net
optical density (net OD) according to Equation (3.4); this was then converted to dose by
fitting it with a fourth degree polynomial function [197][198][199]. The calibration curve
of EBT3 film is shown in Figure 3.8. The calibrated dose response curve of EBT3 film
was energy independent on the photon energy from 6 MV to 15 MV, so the same
calibration curve was used to analyse the 6 MV and 10 MV irradiation [198].
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Where Ipre, Ipost, and Ibckg are the optical intensities for pre and post irradiation, as well as
the transmitted background intensities.
To calculate the correction factor, samples from the same lot of EBT3 films were
cut into 7.0×7.4 cm2 patches to fit the PMMA holder used for MP512 packaging (Figure
3.9). The films were irradiated inside the cylindrical phantom, in the same position as the
detector array, with 6 MV and 10 MV photon beams and a 10×10 cm2 open field at
incident beam angles of 0°, 45°, 90°, 135°, and 180°; the films were then analysed by
following the same procedure for film calibration. A median 3×3 pixels filter was used to
reduce noise. An ROI with 137×137 pixels matches the active area of an MP512
corresponding to 5.2×5.2 cm2. MATLAB 2014b (Math Works Inc., Natick, MA) and the
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polynomial function obtained during the calibration step were used to convert pixels to
doses.

Figure 3.8: The calibration curve of gafchromic EBT3 films using a red
channel.

Figure 3.9: The experiment setup of gafchromic EBT3 films using
MP512 packaging to fit the PMMA holder.
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3.3.4. Angular correction factors
Data collected by the MP512 and EBT3 film with an open 10×10 cm2 field were used to
determine the correction factor for each detector pixel. Increasing the field size beyond
10×10 cm2 for angular calibration does not change the field uniformity or electron
equilibrium within the active area of MP512 that determines the angular response
calibration when 10×10 cm2 field irradiation is used. The angular dependence of MP512
was evaluated in an azimuthal direction (along the x-axis) because the rotation was
longitudinal (y-axis), as shown in Figure 3.6. Because the spatial resolution of the
detectors is different, the (i,j)-th pixel of the EBT3 dose profiles in the x and y direction
was aligned with the (i,j)-th pixel of MP512 using a curve function that obtained a second
order polynomial fit [168]. The response of film at the angular increments 150 needed to
determine an angular correction of MP512 was achieved by interpolating between the
values of films irradiated at 0°, 45°, 90°, 135°, and 180°. The calibration matrix 9 : is the
conversion factor from counts to dose; it was calculated from the ratio between the
response of MP512 in counts for each pixel (i,j) to the dose measured by the EBT3 film
in each pixel (i,j) as a function of the gantry angle , defined as Equation 3.5 and
expressed in units of counts/cGy.

9 : (<) =

>? @ (A)

BCDE @ (A)

(3.5)

Where i is the row index along the x-axis, i.e., the axis perpendicular to the phantom
rotation, and j is the column index of pixels along the y-direction parallel to the axis of
rotation. For each column along the y-coordinate the detector and film did not very much.

58

Chapter 3: Angular dependence and the correction factor

For the open 10×10 cm2 field, the angular response calibration tensor for MP512
(

: (<))

was calculated by dividing the calibration factor at an arbitrary gantry angle 

by the calibration factor at a gantry angle of 0 (Equation 3.6)

: (<)

=

F @ (A)

(3.6)

F @ (+)

3.3.5. Validating the angular response correction factor for a small
field
The angular response of MP512 was verified by irradiating it with open field sizes of 1×1
cm2, 2×2 cm2, 3×3 cm2 and 4×4 cm2, and at gantry angles of 0°, 45°, 90°, 135° and 180°
using 6 MV and 10 MV photons, and by fixing 100 MU and dose rates at 600 MU/min at
each position. At each pixel (i,j), the dose response GH%IJJ
:

%K L

(<) measured by the

MP512 and corrected for angular dependence, was obtained by dividing the measured
response GH′: (<) by the calibration tensor

: (<)

for a 10×10 cm2 field (Equation 3.7).

The methodology used to measure the MP512 response was similar to that described
above.

GH%IJJ
:

%K L

=

>? ′@ (A)
M @ (A)

Where GH′: (<) is the MP512 response signal (counts) for a particular angle, and
is the calibration tensor for the 10×10 cm2 open field.
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3.4. Results
3.4.1. Angular response
Figure 3.10 shows the difference in angular response at the central pixels for MP512 and
EBT3 film. Figure 3.11 shows the intrinsic detector response between 00 and 1800 as a
function of the incidence angles collected from the four central pixels with various field
sizes. These responses are the combined effect of beam attenuation through the silicon
substrate and the fibreglass supporting the detector crystal. The error bars are calculated
as one standard deviation (1SD) for the five measurements repeated in a test state, and
the measurement uncertainty with a maximum variation of ±0.2% at a 95% confidence
interval. The relative response of MP512 decreased as the incident beam angle increased,
giving an average change per degree of 0.18±0.03%. The relative angular response of
MP512 decreased by less than 5% for incident angles between 00 and 600, whereas the
minimum response (largest deviation) of 18.5±0.5% for 6 MV and 15.5±0.5% for 10 MV
was achieved at incidence beam angles between 900-95°. The relative angular response
increased again when it moved towards larger angles, which led to underestimating the
response of 14.3±0.6% and 9.4±1.8% at 1800 for the 6 MV and 10 MV photon beams,
respectively. The data in this study was not distributed normally and the sample size per
group was less than the criteria (n<15), so a non-parametric statistical analysis such as a
Kruskal-Wallis test and a Mann-Whitney U test were used. A Kruskal-Wallis test is
commonly used to compare the difference for three or more independent groups, in this
study, it was carried out to determine the effect of various field sizes (1×1 cm2 to 10×10
cm2) for the same photon energy. While Mann-Whitney U-test is suitable for comparison
of the difference between two independent groups, in this study, it used to find out for the
effect of energy (6 MV and 10 MV) for same field size. There was no significant
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difference in an angular response with values of p = 0.9985 for 6 MV and p = 0.5359 for
10 MV, although the angular response for 1×1 cm2 and 10×10 cm2 field size for a 10 MV
photon beam at incidence angles between 135° to 180° changed by more than 3%, and a
Mann-Whiney U test showed no significant difference with p = 0.5214. Hence, the
angular response of MP512 is not sensitive to field size. However, Figure 3.12 shows the
intrinsic detector response for a 10 ×10 cm2 open field was between 00 and 1800 as a
function of the incidence angle collected from the four central pixels and the beam energy.
The relative angular response for higher energy 10 MV photon beams was less than for 6
MV photon beams. A Mann-Whitney U test to compare the angular response between 6
MV and 10 MV photon energies revealed a significant difference in the angular response
as a function of the beam energy with p = 0.04.

Figure 3.10: A comparison of the central pixel response between MP512 and EBT3
for 6 MV (a) Field size 3×3 cm2, (b) Field size 10×10 cm2.
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(a)

(b)
Figure 3.11: Angular dependence of the averaged four central pixels of the MP512
detector array shown as a function of incident gantry angle for ( a) 6 MV and ( b) 10
MV photons.
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Figure 3.12: Angular dependence of the averaged four central pixels of the MP512
detector array shown as a function of incident gantry angle for an open field size of
10×10 cm2 for 6 MV and 10 MV photons.

3.4.2. Validating the angular response correction factor for a small
field
The beam profile comparisons were evaluated using the shape-preserving interpolant
curve fitting tool in MATLAB which provides 0.01 mm precision that is reflected in a
Table 3.1. The beam profiles of field sizes from 1×1 cm2 to 4×4 cm2 measured with an
MP512 at an incidence angle of 0 degrees were compared to EBT3 films; there was
agreement with the Full Width of Half Maximum (FWHM) and penumbra (20%-80%)
for 6 MV and 10 MV beams within ±1% and 1 mm for FWHM and penumbra,
respectively (
Table 3.1). When the angular dependence is not corrected the MP512 response to beams
at incidence angles other than 0 degrees has a dose profile that is similar in shape to EBT3
film but with a lot of attenuation. This result confirms that underestimating the dose for
angled beams due to the extracameral silicon surrounding each pixel cannot be avoided
for a monolithic solid state detector. After correcting the MP512 measured doses using
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the

: (<)

factor (Equations 3.6 and 3.7), the agreement between MP512 and EBT3 films

improved significantly for field sizes of 2×2 cm2, 3×3 cm2, and 4×4 cm2. The dose profiles
from 2×2 cm2 to 4×4 cm2 measured with the MP512 detector after correction match the
EBT3 dose profiles for all angles within 2% (Figures 3.13 to 3.18) for 6 and 10 MV
photon beams. However, with 6 MV photons and a field size of 1×1 cm2 the cross-plane
depth-dose profiles corresponding to a 900 gantry angle were wrong by almost 6% out
compared to EBT3 film [Figure 3.19(c)]. This larger error occurred because the partial
response of MP512 for small a 1×1 cm2 field for beam incident along the detector plane
is due to secondary electrons generated by photons interacting along the silicon substrate
about 400 micron thick and attenuating stronger that in a phantom. In case of 10×10 cm2
field the contribution of electrons generated in silicon is much smaller because the
response of the detector is mostly due to secondary electrons generated by photons from
the phantom where their (photon) attenuation is less than in silicon. However, with a 10
MV photon beam, the discrepancy between MP512 and film after correction was within
2% for the 1×1 cm2 size field [Figure 3.20(c)] because the scattered electrons have higher
energy which is not absorbed by the printed circuit board and the silicon substrate.
Table 3.1: The difference in FWHM and penumbra width (20%-80%) between MP512
and EBT3 films for various field sizes.
6 MV
FWHM(mm)
FS

10 MV

Penumbra(mm)
Diff

(cm2)

EBT3

MP512

1×1

9.84

(%)

FWHM(mm)
Diff

EBT3

MP512

(mm)

10.06 2.31 2.44

2.82

2×2

19.85 20.02 0.83 2.85

3×3
4×4

Penumbra(mm)
Diff
MP512

(mm)

0.38 10.19 10.41 2.18 2.84

3.14

0.30

3.57

0.71 19.86 20.29 2.17 3.43

3.83

0.39

29.80 30.33 1.81 3.18

3.69

0.52 29.92 30.37 1.49 4.01

4.25

0.24

40.01 40.32 0.79 3.40

3.79

0.39 40.06 40.54 1.19 4.30

4.39

0.09
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Figure 3.13: Dose profiles of 2×2 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 6 MV photon as a function of distance ( mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.14: Dose profiles of 3×3 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 6 MV photon as a function of distance ( mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.15: Dose profiles of 4×4 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 6 MV photon as a function of distance ( mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.16: Dose profiles of 2×2 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 10 MV photon as a function of distance (mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.17: Dose profiles of 3×3 cm2 measured with EBT3 films and MP512 with
and without a correction factor for 10 MV photon as a function of distance (mm) and
dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.18: Dose profiles of 4×4 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 10 MV photon as a function of distance (mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.19: Dose profiles of 1×1 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 6 MV photon as a function of distance ( mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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Figure 3.20: Dose profiles of 1×1 cm2 beam measured with EBT3 films and MP512
with and without a correction factor for 10 MV photon as a function of distance (mm)
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180°
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3.5. Conclusions
This study examined how the field size and photon energy affected the angular response
of MP512, a monolithic detector arrayed with 0.5×0.5 mm2 pixels and a 2 mm pitch; the
angular response of MP512 was almost independent of the field size. Our results suggest
that a using a 10×10 cm2 reference field to calculate the correction factor and apply it to
any field size larger than 1×1 cm2 is feasible. This makes the MP512 a viable option for
small field dosimetry in intensity modulated SBRT or VMAT where the fields shape is
modulated. The method used to calculate the angular correction vector is based on
comparing the EBT3 mapped dose and MP512 detector response to a 10×10 cm2 field
and beam incidence angles between 0 degrees and 180 degrees. When the developed
angular correction vector was used the dose profile measured by MP512 and EBT3 film
for all field sizes at 6 MV and 10 MV photons agreed within 2%, except for the 1×1 cm2
field at 6 MV where the agreement was within 6%. The angular dose of MP512 decreased
by increasing the beam incidence angle to 18.5±0.5% and 15.5±0.5% for 6 MV and 10
MV photon beams, rather than the normal beam incidence (zero degree) where the
minimum was between 90° to 95°. While the MP512 is a large monolithic 2D array
detector, its angular response is similar to or less than of the single diodes presented in
other studies [61], [114], [200], whereas its directional dependence is attributable to the
intrinsic anisotropic configuration of the MP512 silicon detector where each pixel is
surrounded laterally by extra-cameral silicon and by a thin fibreglass printed circuit board
on the back. This packaging creates differences in beam angle dependent attenuation of
the secondary electrons which causes the pixels to become sensitive to angular
dependency; and since the silicon surrounding the pixels is denser than water, secondary
electrons are produced with an energy distribution that differs to that generated in water
which affect the dose measured by the pixels under different beam angles [186], [201]–
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[203]. For 10 MV photon beams, the scattered electrons have more energy than 6 MV
photon beams, which leads to a less pronounced angular response by the MP512.
The discrepancy between the MP512 and EBT3 films of up to 6% for 6 MV
beams and a 1×1 cm2 field at an incidence angle of 900 are due to the different radiation
fractions for a 1×1 cm2 field compared to a 10×10 cm2 field. The partial fraction of
photons attenuated by 0.47 mm thick and 52 mm long silicon substrate has more influence
on how the pixels embedded in silicon with depth respond, whereas the response of pixels
with depth for a 10×10 cm2 field is driven mostly by secondary electrons scattered from
the PMMA to silicon. With the 1×1 cm2 field and 10 MV photon beams, this effect was
less pronounced because the scattered electrons had more energy, leading to a smaller
asymmetry due to PCB and extra-cameral silicon. At field sizes less than 2×2 cm2 for 6
MV photon beams, when a beam is irradiated parallel to the silicon detector array such
as at an incident beam angle of 900 a small field correction factor rather than generic one
for a 10 × 10 cm2 field should be considered to achieve higher accuracy.
The applicability of MP512 for the developed correction vector was studied using
the case of arc delivery in VMAT and IMRT for small lesions. Here, the gantry angles
measured with an inclinometer and synchronised with the MP512 DAQ are the basis of
the list mode data which, in conjunction with the angular correction vector, will provide
corrected integral 2D dose mapping in a particular plane [204]. Measurements using
MP512 will be compared with the EBT3 response for the same VMAT and IMRT
delivery and TPS prediction and will be discussed in Chapter 5.
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Chapter 4
The characteristics of a 2D monolithic
epitaxial detector array as a quality
assurance dosimeter for small field

4.1. Introduction
After being investigated the MP512-Bulk proved to be an excellent QA dosimeter in a
small field, but it is sensitive to degradation from accumulative doses of radiation
[205][63]; this means it requires frequent recalibration to maintain a measurement
accuracy within 2%. Although epitaxial silicon technology has been introduced into
conventional radiotherapy, investigations showed it suffered from radiation hardening
[182][206][207]. To improve the radiation hardness and provide long term recalibration
of the MP512 detector arrays, the CMRP has modified the MP512 base on epitaxial
technology so it is now called MP512-EPI.
This chapter presents a complete dosimetric characterisation of an MP512-EPI by
describing its design and fabrication, and the experimental techniques and setup. The
dosimetric characteristics of this detector were investigated in terms of radiation hardness,
percentage depth dose (PDD), dose per pulse and dose rate (MU/min) dependence, dose
linearity, segmental dose linearity, long term reproducibility, cross-plane profiles in small
fields, and directional dependence. MP512-EPI measurements were compared to the
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Markus ionisation chamber, to gafchromic EBT3 films, and to MOSkin. The result of
MP512-EPI in term of radiation degradation was compared to MP512-Bulk to understand
benefit of epitaxial silicon detector technology can be utilized for development of
radiation hard quality assurance dosimeters. The chapter also presents the detector’s I-V
characteristic measurements to show the leakage currents as the function of the
accumulated dose of irradiation.

4.2. Materials and Methods
4.2.1. MP512-EPI design and fabrication
The MP512-EPI (Figure 4.1) detector has flat array planes with 512 phosphorus n+
implanted pixels fabricated on a 34.13-35.67 µm thick epitaxial layer with a high
resistivity of 100 Ohm·cm (Ω·cm) and grown on top of a low resistivity p+ substrate of
0.001 Ω·cm resistivity and thickness 525±25 µm. This thin epitaxial layer limits the
thickness of detector’s sensitive volume to less than the length of the minority carrier
diffusion while maintaining the stability of the detector’s sensitive volume with the dose
of irradiation. Each sensitive area is 0.5×0.5 mm2 as defined by an n+ phosphorous ionimplant that covers an area of 52×52 mm2 with a high resolution of 2 mm. The p-stop
(p+) is implanted between the sensor pixels to minimise the coupling effect due to
conductive channels being generated between the boron implantations. MP512-EPI is
wire-bonded onto a 5 mm thick tissue equivalent printed circuit board (PCB) that is
connected to the readout system via the connector pins (Figure 4.2). The thin layer of
epoxy covers the entire active area of the detector to protect it from accidental damage
and dust. The MP512-EPI is sandwiched between two 5 mm thick PMMA slabs, while
the covering piece provides an air gap of 0.5 mm for 6 MV photon and 1.2 mm for 10
MV photon measurements [192].
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Figure 4.1: Schematic of the MP512-EPI fabrication and packaging (not to scale).

Figure 4.2: MP512-EPI wire-bonded onto a PCB and the
connector pins.

4.2.2. Data acquisition system (DAQ)
The FPGA data acquisition system was used for the measurements, as discussed in
Chapter 3, Section 3.2.2.
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4.2.3. Electrical characterisation: Current-Voltage (IV) characteristic.
The current-voltage (IV) characteristic or radiation hardness characteristics were
investigated to determine the quality of the p-n junction and the effects of radiation
damage. Radiation can increase the leakage current of silicon detectors which limits the
sensitivity of the silicon diode used to optimise the signal/noise ratio. The IV
characteristic of MP512-EPI was performed before and after irradiation with a high dose
Co-60 gamma source for a total dose of 60 kGy, and an increment 20 kGy per step dose.
A Keithley 230 programmable voltage source was applied to the detector bias, and a
Keithley 199 System DMM/scanner and Keithley 614 electrometer were used to measure
the reverse current (Figure 4.3). The IV measurements and parameters were controlled
using software called LabVIEW (Figure 4.4).

Figure 4.3: I-V characteristic measurement setup.
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Figure 4.4: LabVIEW software interface.

The 14 diodes were randomised to cover the central and peripheral area on the MP512EPI and to determine how detector geometry affected the leakage current. The location
of the selected diodes is shown in Figure 4.5 (yellow highlight). A reverse voltage was
applied to the sensor on the p+ substrate via the bias pins, and the current across the
junction was measured with an ammeter connected to the n+ region of each diode pixel
(Figure 4.6). The voltage ranged from 0 to -60 V, in increments of -0.5 V per step. The
time interval needed to stabilise the current transient measurement was fixed at 1000
msec. The variable scale was set for a current between 2 kpA to 200 nA. Light disturbance
can generate a photocurrent so the detector was kept in a dark environment or sealed box,
as shown in Figure 4.3. The leakage current measurement depended on the temperature
due to electromagnetic interference, so the selected diodes were measured at room
temperature of approximately 298 K (24.85 °C).
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Figure 4.5: Location of selected diodes on the MP512-EPI (yellow highlight).

Figure 4.6: Schematic of I-V test for MP512-EPI.

4.2.4. Radiation hardness.
Silicon diode are sensitive to degradation when the accumulated dose of radiation
increases [205][63], but the extent of damage to the diode depends on the quality of beam
radiation. Typically, a higher energy photon beam such as 15 MV can cause more damage
than 6 MV or 10 MV due to contamination with fast neutrons [208] [209]. Photon
radiation mostly induces point defects in a lattice of silicon crystal, this leads to traps in
the forbidden gap of silicon that acts as centres for generation and recombination. The
length of the minority carrier diffusion decreases which reduces a diode’s sensitivity and
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dose per pulse response modification [173]. The damage caused by radiation also
increases the silicon diode detector’s dark current and temperature dependence. In this
study the MP512-EPI was irradiated with a 2.28 kGy/hr (approximated at the time of
irradiation) from a Co-60 gamma source that provided a mean energy spectrum of 1.25
MeV. All the gamma irradiated by Co-60 was held at the Gamma Technology Research
Irradiator (GATRI), Australia Nuclear Science and Technology Organisation (ANSTO).
The MP512-Bulk and MP512-EPI were irradiated with a total water equivalent dose of
40 kGy and dose increments 10 kGy and 60 kGy with dose increments 20 kGy,
respectively. The 6 MV photon beams (Varian Clinac iX) at the Illawarra Cancer Centre
(ICCC) were used to investigate the detector’s sensitivity to degradation before and after
irradiation. The detector array was placed perpendicular to the iso-centre of the radiation
beam with a solid water phantom of 30×30 cm2 depth of maximum dose (1.5 cm) and 10
cm phantom slab downstream for full back scattering, by fixing the source to surface
distance (SSD) at 100 cm (Figure 4.7). All these experiments were carried out with 10×10
cm2 square filed while delivering 100 MU at a constant dose rate of 600 MU/min. The
measurements were repeated five times to study the detector’s consistency and data
acquisition system. The response of MP512-EPI to radiation was normalised to the
response of the non-irradiated detector (0 kGy).
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Figure 4.7: Schematic of the setup for measuring radiation
degradation.

4.2.5. Percentage depth dose (PDD)
The percentage depth dose is the radiation beam absorbed at the central axis measured at
any depth and normalised to the dose at a depth of maximum (dmax). This curve depends
on the depth of measurement, the beam energy (beam quality), the field size, the source
to surface distance (SSD), and the detector used in the measurement [210]. The PDD
curves show a reduction in the depth and dose functions. The PDD curve is an important
parameter in radiotherapy, and this measurement is needed to ensure the detector is a
suitable quality assurance dosimeter. The PDD were carried out in a solid water phantom
with an MP512-EPI. Because the detector array was covered by 0.5 cm thick PMMA the
PDDs were measured by varying the phantom depth from 0.5 cm to 30 cm. The PDD
curves were measured with 6 MV and 10 MV photon beams and a 10×10 cm2 square field
where the SSD was fixed at 100 cm. The detector was irradiated using 100 MU and a
fixed dose rate at 600 MU/min. The results were compared with MP512-Bulk
measurements under the same conditions. The PDD curves were also compared with the
standard PDD data measured by the Wellhofer CC13 ionisation chamber (cavity volume
is 0.13 cm3, length 5.8 mm and radius 3.0 mm) in water at depths ranging from 1.5 to 30
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cm while the Markus chamber Model N23343 (PTW-Freiburg, Germany) measured the
solid water phantom at depths ranging from 0.5 cm to 10 cm. The overdose measured by
the Markus chamber was due to its small guard ring and large separation; this was
corrected by following the Velkley and Rawlinson Method [211][212][213], [214]. The
dimensions of the Markus chamber obtained from Chen et al. were used to correct the
calculations [215].

4.2.6. Dose linearity
The complexity radiotherapy such as VMAT or IMRT usually delivers the dose range
covers a large variation of MU per segment and fraction. The response of detector arrays
should have linearity with the dose or MUs increasing. The MP512-EPI was placed at a
depth of 1.5 cm in a solid water phantom and 10 cm slab behind detector for full back
scattering condition of 10 cm, fixing SSD at 100 cm. The measurement obtained for both
6 MV and 10 MV photon beams. The doses were delivered ranging from 1 MU to 500
MU using a 10×10 cm2 radiation field.

4.2.7. Dose rate (MU/min) dependence
The advanced technique VMAT and IMRT modulated the dose to deliver a conformal
dose to a tumour by changing the monitor’s unit rate (MU/min), gantry position, and MLC
shapes during radiation. The silicon diode sensitivity on dose per pulse dependence is on
a LINAC that delivers radiation with a pulsed beam and a high instantaneous dose rate
[65][216]. The characteristics of this new detector must be examined in terms of its dose
rate (MU/min) dependence. The pulse base frequency of a Varian accelerator for 6 MV
is 360 Hz, this dose rate delivers a different pulse period and number of pulses per minute,
as shown in Figure 4.8 [217]. To investigate how the duration between pulses affects
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detector sensitivity, an MP512-EPI was irradiated with dose rates ranging from 100 to
600 MU/min and 100 to 400 MU/min for 6 MV photon beams and 6 MeV electron beams,
respectively. The set up for this experiment followed the reference conditions of a 10×10
cm2 size field and SSD at 100 cm at Dmax (1.5 cm) and zref (1.2 cm) for 6 MV photon
beams and 6 MeV electron beams, respectively. By following the TRS-398 protocol, 1
MU was calibrated to a dose of 1 cGy to deliver a water equivalent material at the
reference condition [37]. According to this protocol, the dose rate (MU/min)
measurements corresponded to dose rate from 100 cGy/min to 600 cGy/min. The
sensitivity of MP512-EPI at a particular dose rate was averaged for four central pixels
and average sensitivity was normalised to the maximum dose rate for both energies.

Figure 4.8: The dose rate time-sequence of 6 MV photons for Varian Clinac IX.

4.2.8. Dose per pulse (DPP) dependence
Dose per pulse (DPP) is an integration of the instantaneous dose rate over the pulse width.
Co-60 is a continuous beam that is equal to the instantaneous dose rate and the average
dose rate. A LINAC delivers radiation in a pulse beam series with a high instantaneous
dose rate. The silicon diode is sensitive to dose per pulse so there is some concern when
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a silicon diode is used for measurements in a LINAC machine [65][216]. The DPP
decreased as the SSD increased. The nominal energies of 6 MV x-ray beam (Varian
Clinac iX) were used to study the dose per pulse dependence on the sensitivity of a silicon
diode. The front of the detector array was perpendicular to the horizontal radiation beam
(gantry 90°) at a 1.5 cm depth (dmax) and with a 10 cm solid water slab behind for full
back scattering (Figure 4.9). The MP512-EPI was irradiated using a 10×10 cm2 beam and
by varying the SSD from 100 cm to 370 cm. The frequency pulse timing for 6 MV photon
beams for the Varian accelerator was 360 Hz, giving a dose per pulse ranging from
2.78×10-4 to 0.21×10-4 Gy/pulse. The thimble ionisation chamber Farmer 0.6 cm3
(NE2571) was used for comparison under the same conditions. Charges from the
ionisation chamber were measured using a PTW UNIDOS electrometer with a supply
voltage of -300 volts (V). The MP512-EPI sensitivity (pC/Gy) S was a ratio of the charge
collected (pC) from an average of the four central pixels of MP512-EPI per unit absorbed
dose (Gy) as measured by the ionisation chamber at the same SSD (Equation 4.1). The
dose per pulse response was calculated by normalising the sensitivity ratio at any SSD to
the detector sensitivity at SSD 100 cm (2.78×10-4 Gy/pulse) (Equation 4.2) [218].
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Figure 4.9: A schematic of the gantry angle orientation for measuring
dose per pulse.

4.2.9. Output factor for small field size
The output factors are defined as a dose for a particular field size ratio to the dose from
the reference field size of 10×10 cm2 [50]. The output factors decrease as the field size
decrease and decrease even faster in a small field due to lateral electron disequilibrium,
source occlusion, and detector perturbation. The output factor measured by the detector
in small radiation fields is a function of the averaging effect of the sensitive volume and
the electronic density of the surrounding material [219]. The output factors were
measured at a depth of 10 cm RMI 457 solid water phantom and fixed SSD at 90 cm
(Figure 4.10). The detector array was irradiated on 6 and 10 MV photon beams with fixed
100 MU and a dose rate of 600 MU/min. The detector array was irradiated using open
square fields ranging from 10×10 cm2 down to 0.5×0.5 cm2. To avoid the dose averaging
volume effect the response of the central pixel (0.5×0.5 mm2) at specific field size was
used to calculate the output factors by comparing the OF measured with the MOSkin and
gafchromic EBT3 film measurements under the same conditions.
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Figure 4.10: The MP512-EPI in the output factors measurement setup.

4.2.10. Angular response
The MP512-EPI is a planar detector array whose active sensitivity consists of a
monolithic substrate. This configuration is mainly concerned with the angular response
when the beam is not perpendicular to the detector (Refer to Chapter 3)[220][221]. In this
study, the angular response of MP512-EPI was under the same orientation discussed in
Chapter 3 where irradiation was carried out by rotating the gantry from 0° to 180° at
increments of 10° and finer increments of 1° at incidence beam angle of 90°±10° using a
10×10 cm2 square field. The response at a particular angle was normalized to the detector
response at an incidence beam angle of zero. The results were compared to the MP512Bulk in order to understand how substrate affects the angular response.

4.2.11. Segment linearity
Step and shoot IMRT is a series of low MU delivery where the maximum segment is
approximately 15 segments per each field [48], therefore the innovation detector is used
as a verification dosimeter and the measured linearity of segmental beam delivery should
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be investigated. An MP512-EPI was placed at a depth of 1.5 cm of a water equivalent
solid phantom and full backscatter, fixing the SSD at 100 cm. A series of 10×10 cm2
beams were carried out at a dose rate of 600 MU/min. The constant dose of 50 MU was
irradiated by varying the segments from 1 to 25; the MP512-EPI response for each
segment was normalised to the one segment of 50 MU deliveries.

4.2.12. Long-term reproducibility
This experiment set out to estimate the long term sensitivity and stability of MP512-EPI
over 12 months with the average dose of photons of 500 Gy. Irradiation was measured
after pre-irradiation at 60 kGy and was repeated for one to twelve months. In this
experiment an MP512-EPI was placed at a depth of 1.5 cm in a solid water phantom and
delivered a fixed beam of 10×10 cm2 with 100 MU and at a dose rate of 600 MU/min;
the SSD was fixed at 100 cm, and all the measurements used 6 MV photon beams. The
response from an average of four central pixels was normalised to the primary irradiation
time using the uncorrected calibration factor; standard deviation was calculated using five
consecutive exposures.

4.2.13. Measuring the cross plane profiles
The cross plane profiles of MP512-EPI were measured in a solid water phantom at a depth
of 10 cm. The central pixel of the detector array was aligned perpendicular to the central
axis of the beam, and the set up position was tuned with a 0.5×0.5 cm2 beam. 6 MV
photon beams irradiated a series of small fields collimated by the jaw from 1×1 cm2 to
4×4 cm2 with a constant dose rate of 600 MU/min and a fixed 100 MU. In this study the
MLC was completely retracted from the irradiation fields. The central beam profiles of
MP512-EPI were evaluated with reference to gafchromic EBT3 films in terms of full
width and half maximum (FWHM) or at a 50% isodose and penumbra region (20%-80%
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isodose). The EBT3 films were cut into 7×7 cm2 sizes and performed under the same
conditions. Each film was scanned by the Microtrex ScanMaker i800 flatbed scanner with
48-bit depth of colour and a spatial resolution of 72 dpi (equivalent to a pixel size of 350
µm). The difference in the FWHM between MP512-EPI and EBT3 films was calculated
as shown by the equation below.

∆ [\G =

>?P Q BCD]
BCD]

^100%

(4.3)

4.3. Results
4.3.1. I-V Characteristics
Figure 4.11 shows the I-V characteristics of selected diodes of MP512-EPI in the function
of logarithmic scale reverse current (pA) and reverse voltage (V). This characteristic was
measured before irradiation and then compared to post irradiation for each pixel. With
non-irradiation, the I-V curves show that the current has increased rapidly as the voltage
increased until it reached approximately -10 V after which it continued to increase slowly.
The I-V curves showed a breakdown voltage of approximately of -58 V. Increased
radiation led to an increase in the leakage current of the diode but there was a large
variation between the non-irradiated and an irradiated 2 Mrad (20 kGy). However, this
increased dose of radiation after a 20 kGy did not effect the leakage current. I-V curves
also exhibited a small variation for all selected diodes, whereas the MP512-EPI had
excellent uniformity and a slight variation between each irradiated diode at the same
accumulated dose (Figure 4.12).
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(a) channel 16

(b) channel 28

(c) channel 41

(d) channel 153

(e) channel 155

(f) channel 163

Figure 4. 11: Leakage current measured in reverse direction on selected channels of
MP512-EPI comparison between prior-irradiation and after irradiation.
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(g) channel 224

(h) channel 288

(i) channel 299

(j) channel 334

(k) channel 351

(l) channel 363

Figure 4. 11: Leakage current measured in reverse direction on selected channels of
MP512-EPI comparison between prior-irradiation and after irradiation.
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(m) channel 441

(n) channel 454

Figure 4.11: Leakage current measured in the reverse direction on selected channels
of MP512-EPI comparison before and after irradiation.

(a) Prior-irradiation
Figure 4.12: The results of I-V characteristic comparison of each channel for (a) Prior
irradiation, and (b) After 20 kGy irradiation.
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(b) After 20 kGy dose of irradiation
Figure 4.12: The results of I-V characteristic comparison of each channel for (a) Prior
irradiation, and (b) After 20 kGy irradiation.

4.3.2. Radiation hardness
Figure 4.13 shows the response of MP512-EPI and MP512-Bulk as a function of relative
sensitivity and accumulated dose of radiation. The error bar represents the ±1SD of five
repeated measurements (<2%). The sensitivity of MP512 dropped rapidly after irradiation
with 10 kGy, while stability after irradiation with 20 kGy was then obtained. The
detectors fabricated on a thin p-Si epitaxial layer with a high resistivity of 100 Ω cm
(MP512-EPI) show a higher constant sensitivity than the detectors fabricated at a low
resistivity of 10 Ω cm p-Si (MP512-Bulk). The response of MP512-EPI decreased less
than 3% and was constant within 0.3% after a given dose of 40 kGy. The MP512-EPI
demonstrated excellent sensitivity and stability after pre-irradiation with a sensitivity
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degradation of 0.3%/10 kGy while the degradation response of MP512-Bulk was 5%/10
kGy.

Figure 4.13: The relative sensitivity of MP512- Bulk and MP512- EPI
as a function of the accumulated dose for Co- 60 gamma source,
normalised to a zero dose response.

4.3.3. Percentage depth dose (PDD) measurement
Figure 4.14 shows a good agreement of percentage depth dose (PDD) for 6 and 10 MV
photon beams between MP512-EPI and CC13, Markus chamber, and MP512-Bulk. The
PDD curves measured by MP512-EPI were slightly lower than those measured with
CC13 and MP512-Bulk. The maximum discrepancy between MP512 and IC for 6 MV
beams was approximately 1.5% and 0.8% at a depth of 30 cm for MP512-EPI and MP512Bulk relative to Dmax. Similar variations occurred when 10 MV beams were measured
relative to Dmax; here the maximum discrepancies were 1.3% and 1% for MP512-EPI
and MP512-Bulk. These results are commensurate with their dose per pulse response and
are easy to correct, and the discrepancy is within allowable error of ±2%.
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(a)

(b)

Figure 4.14: Percentage depth dose measurement of MP512 compared to the Markus
and CC13 ionisation chambers for (a) 6 MV and (b) 10 MV photon beams.

4.3.4. Dose linearity
The response of MP512-EPI at doses ranging from 1 to 500 MU show an excellent
linearity for the 6 MV and 10 MV photon energies, and the regression coefficient r2 is
almost equal to 1 (Figure 4.15). The linearity of MP512-EPI in this study had the same
trend as the MP512-Bulk, as presented in Aldosari et al study [170].
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Figure 4.15: The average response of four central pixels of MP512EPI as a function of the accumulated dose (MU).

4.3.5. Dose rate (MU/min) dependence
The change in MP512-EPI sensitivity as a function of the dose rate (MU/min) is shown
in Figure 4.16; the error bar indicated the uncertainties after measuring the (1SD) five
times. The maximum variation was within ±0.5% for the 6 MV photon and 6 MeV
electron energies; this means the MP512-EPI response is independent of dose rate for the
clinically relevant MU/min.
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Figure 4.16: Variation of MP512-EPI response as a function
of the dose rate ( MU/ min) for 6 MV photon and 6 MeV
electron beams.

4.3.6. Dose per pulse (DPP) dependence
Figure 4.17 shows the variation of detector sensitivity (pC/Gy) as a function of the dose
per pulse of MP512-Bulk and MP512-EPI at 6 MV with an average uncertainty of five
times the measurements was ± 2% (1SD). The sensitivity response decreased as the dose
per pulse of both detectors decreased. The MP512-EPI fabricated at a high resistivity of
a 100 Ω cm p-Si epitaxial layer had a reduced sensitivity of up to 8% while the MP512Bulk fabricated at a low resistivity 10 Ω cm p-Si had a reduced response of approximately
3% at a dose per pulse change of 10 times (at a minimum dose per pulse of 2.11×10-4
Gy/pulse or SSD 370 cm). However, this reduction in sensitivity is within ±2% for both
detector arrays at a clinically relevant distance (SSD less than 150 cm).
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Figure 4.17: Sensitivity response of MP512-Bulk and MP512-EPI
detectors as a function of dose per pulse for 6 MV photon beam.
These responses were normalised to a dose per pulse of 2. 8×10- 4
Gy/pulse at the source to a surface distance of 100 cm.

4.3.7. Output factor for small field size
Figure 4.18 shows the output factors measured by MP512-EPI and MP512-Bulk
compared to the MOSkin and gafchromic EBT3 films for 6 and 10 MV photon beams.
The results show an excellent agreement within ±2% and ±3% for all field sizes ranging
from 10×10 cm2 down to 0.5×0.5 cm2 for 6 MV and 10 MV photon energies. This is
partially due to the small area of pixels of 0.5×0.5 mm2 for MP512-EPI and a suitable
optimised air gap above MP512-EPI.
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(a)

(b)

Figure 4.18: The output factors measured by MP512- EPI and normalised to a
10×10cm2 field radiation compared to those measured by MP512- Bulk, MOSkin and
EBT3 film for (a) 6 MV and (b) 10 MV photon beams.

4.3.8. Angular response
The angular response of MP512-EPI decreased as the incident beam angle decreased due
to their intrinsic configuration and material; this resulted in a difference in attenuation
and a scattering of photons and electrons that reached the active volume of the pixels
while irradiating from different directions. Figure 4.19 and Figure 4.20 show that the
relative angular response has normalised to the incident angle zero for MP512-EPI and
MP512-Bulk as the incident beam angle increased from 0° to 180°. The angular response
of both detectors was similar, with any difference being between ±2% (Figure 4.20).
Maximum variation relative to incident beam angles of 17.55±0.32% and 16.11±0.40%
were present at incident beam angles between 90° to 100° for 6 MV and 10 MV photon
beams. The angular response depends on photon beam energy, as shown in Figure 4.19,
as determined by the difference in the photon and electron scattering conditions.
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Figure 4.19: A comparison of the average response of four
central pixels between 6 and 10 MV photon beams for
MP512-EPI.

(a)

(b)

Figure 4.20: A comparison of the average response of four central pixels between
MP512-EPI and MP512-Bulk for (a) 6 MV and (b) 10 MV photon beams.

4.3.9. Segment linearity
Figure 4.21 shows the response of MP512-EPI as a function of the dose segments of a
constant 50 MU dose where the response increased with increasing irradiation segments.
With segments of 2 MU or larger, MP512-EPI responded within ±2%. Figure 4.22 shows
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the signal (pC) from the central pixel acquired during segmental beam irradiation where
MP512-EPI had excellent uniformity and a repeatable dose response even after delivery
with a low MU and large segments.

Figure 4.21: The response of MP512- EPI as a function of a
segmental monitor unit (MU) normalised to 1×50 MU.

4.3.10. Long-term reproducibility
Figure 4.23 shows the relative sensitivity of MP512-EPI as a function of time
measurements where sensitivity remained stable after photon irradiation up to 500 Gy
over a period of 12 months. The change in reproducible sensitivity was within ±0.9%,
with two standard deviations of 0.03; this result indicates that MP512-EPI could be used
without recalibration for one year.
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(a)

(b)

(c)

(d)

(e)
Figure 4.22: The response of MP512- EPI from the central pixel during segmental
beam irradiation as a function of acquisition time; (a) One segment with 50 MU each,
( b) Two segments with 25 MU each, ( c) Five segments with 10 MU each, ( d) Ten
segments with 5 MU each, and (e) Twenty five segments with 2 MU each.
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Figure 4.23: The average response of four central pixels of
MP512- EPI as a function of time ( months) normalised to the
first acquisition after pre- irradiation of 60 kGy. The standard
deviation is smaller than the marked symbol.

4.3.11. Measuring the cross plane profiles
Figure 4.24 and Figure 4.25 shows half of the cross plane profile measured by MP512EPI and gafchromic EBT3 film for field sizes ranging from 1×1 cm2 to 4×4 cm2. These
illustrations show more detailed resolutions. The cross plane profiles for 6 MV photons
have excellent agreement between the MP512-EPI and EBT3 films within ±1% and 0.6
mm for FWHM and the penumbra region. These results are similar to the MP512-Bulk
presented in a previous study. The cross plane profiles for 10 MV photons show a slight
overestimation of FWHM, with a different value for a 1×1 cm2 field of up to 1.5%,
however the difference for the penumbra region is still within 0.6 mm; this percentage
difference decreases as the field size increases. The FWHM, penumbra width and
percentage differences are summarised in Table 4.1.
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Table 4.1: The FWHM and penumbra width measured by MP512-EPI and gafchromic
EBT3 films
Field

6MV

10MV

size

EBT3

(mm)

MP512-EPI

Differences

EBT3

MP512-EPI

Differences

FWHM

Penumbra

FWHM

Penumbra

FWHM

Penumbra

FWHM

Penumbra

FWHM

Penumbra

FWHM

Penumbra

(mm)

(mm)

(mm)

(mm)

(%)

(mm)

(mm)

(mm)

(mm)

(mm)

(%)

(mm)

10

9.95

2.43

10.04

2.95

0.94

0.52

10.18

2.83

10.34

3.37

1.57

0.53

20

19.95

2.85

30.02

3.35

0.33

0.50

19.86

3.43

20.13

3.72

1.40

0.29

30

29.91

3.13

29.95

3.66

0.14

0.53

29.92

4.01

30.11

4.58

0.65

0.57

40

39.94

3.23

39.99

3.84

0.15

0.60

40.06

4.30

40.20

4.87

0.36

0.57

Figure 4.24: Cross plane profiles measured by MP512-EPI and EBT3 film for 6 MV
photon beams; (a) field size 1×1 cm2, (b) 2×2 cm2, (c) 3×3 cm2 and (d) 4×4 cm2.
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Figure 4.25: Cross- plane profiles measured by MP512- EPI and gafchromic EBT3
film for 10 MV photon beams; (a) field size 1×1 cm2, (b) 2×2 cm2, (c) 3×3 cm2 and
(d) 4×4 cm2.

4.4. Conclusions
A 2D monolithic detector array MP512-EPI was developed and characterised by regrading the radiation hardness, long term stability, PDD, dose per pulse measurement,
output factor, dose linearity, angular response, cross plane profiles and segment linearity
using 6 MV and 10 MV photon beams and 6 MeV electron beams for the dose rate
response. The MP512-EPI characteristics demonstrated the usefulness of detector arrays
as a quality assurance tool for radiation therapy. The detector’s high spatial resolution of
2 mm and small active area of 0.5×0.5 mm2 means it can be used in small field
measurements without the effect of radiation perturbation from averaging volume
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measurement. Moreover, silicon substrate resistivity and the thickness of an active silicon
layer from which a charge is collected will determine the dosimetric response of MP512.
A modified detector with epitaxial technology improved its long term stability and
sensitivity with an accumulated dose of approximately 0.3%/10 kGy, unlike the MP512Bulk fabricated on bulk silicon (5%/10kGy). This is because the initial diffused length of
electrons in 100 Ω cm epi layer is longer than the 35 µm thick epitaxial layer. Degradation
of the diffused length does not inherently depend on the collected charge until the diffused
length is less than 35 µm. In the MP512-Bulk, any deterioration of the diffused length
creates a deficit in charge collection, so the trade off is a higher variations of dose per
pulse for an MP512-EPI pre-irradiated with 60 kGy compared to a MP512-Bulk preirradiated with 40 kGy. However, at a typical treatment distance corresponding SSD <150
cm (fixing source to iso-centric, SAD setup) and for all beam angles, the sensitivity of
MP512-EPI and MP512-Bulk in terms of their dose per pulse varies within ±2%, although
MP512-EPI provides good long term stability over a 12 month period or photon
irradiation up to 500 Gy; these good characteristics means this detector does not need
frequent recalibration.
The output factor measured by MP512-EPI with 0.5 and 1 mm thick air gaps
above the detector surface for 6 and 10 MV photon beams, respectively, agreed with
gafchromic EBT3 film and MOSkin within ±2% for 0.5×0.5 cm2 fields, unlike in the
previous study where MP512-Bulk had a 1.2 mm thick air gap for 6 MV photon beams
had an over response of approximately 4% for fields less than 1×1 cm2 [170]. This was
partially due to 0.5×0.5 mm2 area of pixels and the optimised air gap above MP512. The
predominant electron scatter in the silicon diodes cause increased sensitivity to a small
field size compared to the reference field because the density relative to water was higher
[222]. Overestimating the diode detector due to a small field size can be mitigated by
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providing a wide enough air gap above the detector, the wide of this air gap depends
mainly on the design of the diode detector [223].
The packaging and intrinsic asymmetry of the 2D monolithic detector array
MP512 affects its intrinsic angular dependence [220][221]. The angular response of
MP512-EPI fabricated on an epitaxial layer with a high resistivity of varied by ±2% when
compared to the low resistivity bulk subtract (MP512-Bulk); this means the angular
response of MP512 is independent of its resistivity and substrate type bulk or epitaxial..
The angular correction factor must be applied where the detector is not perpendicular to
the radiation beam in order to deliver accurate pre-treatment measurements (refer to
Chapter 3). The MP512-EPI demonstrated excellent dose linearity for small mu range
(1-10 MUs) and large dose range (10-500 MUs); it also responded very well to the dose
segments, especially large segments and small MUs (25×2 MU) within ±2%. This result
confirms that MP512-EPI is a suitable verification tool for step and shoots and dynamic
IMRT. Conventional radiotherapy usually delivers dose rates from 100 to 600 MU/min,
whereas advanced treatment machines such as True beam (Varian) which deliver beams
using flattening filter free or Cyberknife, deliver dose rates of approximately 800 MU/min
up to 2400 MU/min [24][224]. Although the dose rates range from 100 to 600 MU/min,
the measurements were within ±1%, which cannot conclude that MP512-EPI can provide
stable response at dose rates that are higher than 600MU/min. Further study of dose rates
and doses per pulse is warranted, particularly for flattening filter free beams.
A high resolution MP512-EPI (2 mm) was needed to measure small fields of 1×1
cm2 with an acceptable value in FWHM and the penumbra region for clinical use [60],
whereas this study only investigated the sizes of simple square fields. Further study is
needed using MP512-EPI in order to evaluate a patient qualification for small intensity
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modulated treatment fields. A clinical QA using MP512-EPI in homogeneous and
inhomogeneous phantoms will be presented in Chapter 5.
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Chapter 5
Clinical implementation of a 2D
monolithic epitaxial detector array for a
small intensity modulated field

5.1. Introduction
SBRT is a complex treatment that uses the IMRT and VMAT technique with a high dose
per fraction and a steep dose gradient. Verifying the dose is the major process needed to
guarantee an accurate dose delivery to the patient. Pre-treatment QA or end-to-end test is
used to verify treatment delivery, as well as calculating the treatment planning dose, the
data transmission system from TPS to the linear accelerator, and the actual dose delivery
[225]. The absolute dose and dose distributions of treatment planning are verified by
comparing them with the actual dose measurements using a 1D, 2D, or 3D dosimeter.
Several commercial 2D arrays have recently been used as a QA tool to measure the
phantom such as MapCHECK (SunNuclear, Melbourne, Florida-USA), Octavius 1000
SRS (PTW-Freiburg-Germany) and MatriXX (IBA Dosimetry, Bartless, TN), but their 5
mm and 10 mm spatial resolutions are too coarse to detect any errors in the TPS, or the
delivery system for small irradiation fields [226][225][227][102]. This lack of
information can lead to an inaccurate treatment delivery. The MP512-EPI is designed for
patient specific QA in small field treatments with a high spatial resolution of 2 mm pixel
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pitch; a dosimetry characteristic that has proved it can be used as a quality assurance tool;
as discussed in Chapter 4.
Although the MP512-EPI is angular dependent has a maximum deviation with
respect to a zero angle up to 18% at a gantry incidence angle of 90°, the angular correction
factor works well with cross-beam profiles between MP512-EPI corrected and
gafchromic EBT3 films for small static irradiation beams down to 1×1 cm2 fields within
±2%, as discussed in Chapter 3.
This chapter describes the clinical implementation of MP512-EPI as a patient
specific quality assurance dosimeter for small intensity modulation fields of IMRT and
VMAT delivery to a homogeneous and inhomogeneous phantom based on Pinnacle3
version 14 treatment planning system (TPS). The planar dose reconstructions of MP512EPI have verified a comparison to EBT3 film dose measurement and TPS calculation
dose.

5.2. Materials and Methods
5.2.1. Two-dimensional monolithic epitaxial detector array (MP512EPI)
The 2D monolithic epitaxial detector array used for the measurements was the MP512EPI; it consists of 512 diode pixels over an area of 52×52 mm2 with a high spatial
resolution of 2 mm pixel pitch, as discussed in Section 4.2.1.

5.2.2. Data acquisition system (DAQ) and inclinometer
The MP512- EPI data acquisition system ( DAQ) is based on a 64- channel analog frontend electrometer ASIC chip where each chip is interfaced to a quad analogue- to- digital
converter (ADC). The ADC output is synchronised and the channel is de- randomised by

110

Chapter 5: Clinical implementation of a MP512-EPI

a field programmable gate array (FPGA) that also manages the synchronisation with the
sync pulse of the LINAC to acquire the detector current discussed in Section 3. 2. 2. In
this study, the inclinometer attached to the gantry stand utilised the angular correction of
MP512-EPI during VMAT arc delivery for any gantry angle increment (Figure 5.1).
The ADIS16209 dual-axis digital inclinometer has 0.025° angular resolution and
a very accurate measurement state within ±0. 1° [ 2 2 8 ] . The inclinometer can operate at
both single-axis (±180°) and dual-axis (±90°) using a standard power supply voltage of
3. 3 V. The function block diagram of the inclinometer is shown in Figure 5.2. The
inclinometer data of gantry rotation during irradiation was synchronised with the detector
acquisition (ADC output) signal and de-randomised by FPGA using the same sync pulse
of the LINAC. A schematic diagram of the DAQ system synchronised with the
inclinometer is shown in Figure 5.3. Data acquisition is transferred via USB2.0 to the inhouse software interface called Magic Suite version AFE_MP- 512i. This software can
store the inclinometer function and also display the instantaneous detector response for
each gantry angle and integral detector for all the delivery angles ( Figure 5.4) . The
acquisition data can be used for online and offline analysis and it can reset the parameter
of the inclinometer in the actual experimental setup (Figure 5.5).
To validate the inclinometer measurement, the gantry angle measured was
compared with the gantry angle indication stored by Varian MLC controller software.
Gantry information is recorded in binary format every 50 minutes, and then exported to
the DynaLog files that also contain essential treatment parameters such as the gantry
angle, collimator angle, couch angle, jaw settings, and MU delivery and MLC leaf
positions [229].
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Figure 5.1: The CMRP phantom with the MP512-EPI inserted in the coronal
plane and associated device, DAQ, and inclinometer.

Figure 5.2: The function block diagram of ADIS16209
inclinometer [228].
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Figure 5.3: Schematic diagram of data acquisition system (DAQ) synchronised with
the inclinometer.

(a)

(b)

Figure 5.4: The software interface Magic Suite; (a) the inclinometer indicator and (b)
the angle (degrees) as a function of time.
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Figure 5.5: Inclinometer settings function

5.2.3. CMRP cylindrical phantom and insertions
The 30 cm diameter by 40 cm long CMRP cylindrical phantom was used to measure the
clinical validation plans; it was designed and developed to fully verify an actual gantry
beam delivery for IMRT and VMAT, where the phantom produced a PMMA density of
1.15-1.19 g/cm3, as discussed in Section 3.2.3. This phantom has a 15.5×20.5×5 cm3
central slot into which homogeneous and inhomogeneous holders can be inserted. Both
holders were designed and developed in-house to allow the MP512-EPI detector and films
to be positioned at the isocentre of the CMRP phantom.
5.2.3.1. Design and fabrication of the homogeneous insertion
The homogeneous holder was made from PMMA with the same specifications as the
CMRP cylindrical phantom; it is 5 cm thick and has a 1 cm central cavity for an MP512EPI and its packaging (Figure 5.6). The 18.5 cm length of the lower part of the holder
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was designed to support the detector’s electronic boarding to stop detector from shifting
as the boarding sags due to gravity during experiments.

Figure 5.6: The homogeneous holder and MP512-EPI packaging.

5.2.3.2. Design and fabrication of an inhomogeneous insertion
Tissues with different densities pose a challenge in clinical calculation and optimisation
because determining a steep dose gradient region and penumbra is complicated, as is
delivering an accurate dose to the heterogeneous region such as the thorax with the lungs,
heart, and bones. To use an MP512-EPI to diversify clinical treatment, a holder and
insertions were designed and developed by CMRP. Both items were made from red cedar
because its physical density of 0.38 g/cm3 is equivalent to human lungs [230]. The holders
have upper and lower parts that are connected with two pinpoints of carbon fibre inside
two holds on the larger holder (Figure 5.7a). The inhomogeneous insertion section was
established in two 1 cm thick squares that enable gafchromic EBT3 film and MP512-EPI
to be placed inside, as shown in Figure 5.8. The MP512-EPI detector without a PMMA
cover was sandwiched between two inhomogeneous slaps and fixed to the holder, as
shown in Figure 5.7b. These insertions were moulded into two types, a spherical shape
with a large water equivalent size of 1 cm3 and 2 cm3 (density of 1 g/cm3) to represent a
tumour in the lung, while the second insertion has no tumour representation (Figure 5.8).
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(a)

(b)

Figure 5.7: The inhomogeneous holder; (a) without and (b) with MP512-EPI.

(a)

(b)

Figure 5.8: The inhomogeneous insertion; (a) The upper and lower part of the insert,
and ( b) schematic cross- section of the inhomogeneous insertion with a tumor inside
(not to scale).

5.2.4. Computed tomography (CT) scan
Radiation therapy needs electron density data so that the treatment planning can be
calculated precisely. CT image datasets provide patient anatomy and structure, including
the CT number or Hounsfield units (HU) that can be converted to information on electron
density. The CMRP cylindrical phantom with homogeneous and inhomogeneous
insertions was carried out by computed tomography (CT) using SOMATOM (Siemens
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Healthineers, Erlangen, Germany) at ICCC Wollongong hospital (Figure 5.9). Three
small markers were placed on the phantom surface to correspond to the central detector
reference. Two imaging datasets with and without a detector inside the phantom were
carried out for each holder. Axial slices 2 mm and a 512×512 matrix resolution were
acquired for the homogeneous and inhomogeneous holder insertions by following the CT
scan protocol for radiation therapy [231][6]. Typical scanning extends over the length of
the entire phantom by avoiding any electronic part of the detector. The CT images with
and without detectors are shown in Figure 5.10 and Figure 5.11. The cylindrical phantom
data sets were sent to the Pinnacle3 TPS.

(a)

(b)

Figure 5.9: MP512-EPI and phantom setup for CT scan (b) the lead marker used for
reference points.
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(a)

(b)

Figure 5.10: The CT images for the homogeneous holder ( a) with MP512- EPI, and
(b) without MP512-EPI.

(a)

(b)

Figure 5.11: CT images of the inhomogeneous holder; ( a) without MP512- EPI and
(b) with MP512-EPI and with a hidden tumour.

5.2.5. Clinical planning and optimisation
Pinnacle3 version 14 (Philips Radiation Oncology Systems, Fitchburg, WI, USA) was
used as a treatment planning system to conduct clinical experiments. An adaptive
convolution superposition was used to calculate 6 MV photon beams on a 2 mm3 dose
grid resolution. This algorithm is a fast model-based 3D dose calculation method
developed by Mackie et al. and AhnesjÖ based on dose spread array (kernel) convolved
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with energy fluence through the medium volume (TERMA; Total Energy released per
unit Mass) that accounted for the polyenergetic spectrum [232][233]. The algorithm
accounts for beam attenuation, primary and secondary scattered electrons changing in
heterogeneous medium, as well as the beam modifier and patient contour effects using a
ray-tracing technique during the superposition [234]. To account for heterogeneities, the
kernels are density-scaled during superposition by “collapsed cones” that using a single
ray corresponding to the central axis of a cone model in space, the set of cone utilised a
lattice of rays [235]. Several studies have been showed that collapsed cone convolution
(CCC) using in Pinnacle provide a high accuracy calculation in the heterogeneity medium
such as lung and bone by revealed insignificant differences between predicted dose
distribution measured, and Monte Carlo simulated dose [236]–[238].
5.2.5.1. Homogeneity plan
The clinical IMRT and VMAT plans for a small brain tumour (GTV size 2.5-3 cm) were
transferred to the CMRP homogeneous phantom CT datasets. The isocentre of the clinical
plan was aligned with the isocentre of the detector, and each plan was recalculated without
changing the clinical planning parameters. Both plans delivered a nominal 2 Gy per
fraction to the target volume. Seven fixed gantries at 0°, 50°, 100°, 150°, 210°, 260° and
310° were to generate the step and shoot IMRT plans. The plan was delivered with a total
of 369 MU. The VMAT plan consisted of a full arc (360°) using a four-degree control
point (CP) angular increment with a total of 90 CP and delivered 410 MU.
5.2.5.2. Inhomogeneity plan
A small 1 cm3 solid water equivalent within the inhomogeneous phantom was used to
represent the GTV of a lung tumour for IMRT and VMAT delivery. The PTV was
extended by 0.5 cm in every direction. A nominal 3.5 Gy per fraction was delivered to
the target volume, and six fixed gantries of 0°, 50°, 120°, 180°, 240° and 310° were used
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to generate the step and shoot IMRT plans. The plan was delivered with 757 MU. The
VMAT plan consisted of a full arc (360°) using a four -degree control point (CP) angular
increment with 90 CP and a dose delivery of 835 MU (2.32 MU/degree). A summary of
the planning parameters for both phantoms is shown in Error! Reference source not
found.. The dose distribution recalculated in a CMRP phantom is shown in Figure 5.12.
The 3D dose volume was exported as a DICOM dose file, and MATLAB 2016b (Math
Works Inc., Natick, MA) was used to extract the planar dose distributions that
corresponded to the specified detector measured plane. The TPS dose distributions were
compared to the MP512-EPI and EBT3 film dose measurement.

(a)

(b)

Figure 5.12: Pinnacle3 version 14 TPS screenshots of the dose distribution crosssections through the iso- centre of the CMRP cylindrical phantom for axial, sagittal
and coronal plane; (a) IMRT plan and (b) VMAT plan.
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Table 5.1: Treatment delivery parameters for homogeneous and inhomogeneous
phantoms.

Pinnacle3 Planning parameters
Phantoms

Dose
(Gy/Fx)

Homogeneity

2

IMRT

VMAT

Gantry

MU

Gantry

CP

MU

0°,50°,100°,

369

360°

4°

410

757

360°

4°

835

150°,210°,
260°, 310°
Inhomogeneity

3.5

0°,50°,120°,
180°, 240°,
310°

5.2.6. Gafchromic EBT3 film
In this study, EBT3 film (Ashland Advanced Materials, Bridgewater, NJ) with batch
numbers 04071601 and 05181502 were used as a reference dosimetry tool for comparison
to MP512-EPI. The curves of these films were calibrated for each batch number, and then
the films were cut into 7×7 cm2 size pieces to fit into the homogeneous and
inhomogeneous holders (Figure 5.13). The films were scanned before and after being
irradiated for 48 hours by the Microtrex ScanMaker i800 flatbed scanner and Epson
Expression 10000 XL. Each film was aligned in the centre of the scanner and scanned six
times with 48-bit colour depth of RGB colour channels and a spatial resolution of 72 dpi
(equivalent to a pixel size of 0.35278 mm). The process of calibrating and analysing the
films was discussed in Chapter 3, Section 3.3.3.
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(a)

(b)

Figure 5.13: Gafchromic EBT3 film cutting pieces using for patient verification; ( a)
Homogeneity holder and (b) Inhomogeneity holder.

5.2.7. Verifying the clinical delivery
All measurements were carried out with a Varian Clinac iX (Varian Medical System, Palo
Alto, CA) at ICCC Wollongong hospital. The LINAC is equipped with a 120-leaf
Millennium multi-leaf collimator system where the inner 80 leaves provide a leaf width
of 0.5 cm and 1 cm for the remaining outer leaves. Before the detector was used as a
dosimeter in clinical verification, MP512-EPI had performed equalisation and relative
dose calibration as discussed in Section 3.3.1. The MP512-EPI was inserted into the
homogeneous and inhomogeneous holder to deliver head and lung treatment,
respectively. The detector array inside the holder was placed in the coronal plane position
of the PMMA cylindrical phantom (Figure 5.1). The phantom was put onto the middle of
the couch to avoid colliding with gantry while rotating around the phantom. To minimise
couch attenuation error, the phantom was place in the same location relative to its location
when the couch attenuation factor was measured. The centre of the detector was aligned
to the isocentre of the radiation beam using a 5×5 mm2 field to reposition the vertical,
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lateral and longitudinal axis to a setup uncertainty within ±1 mm. The inclinometer was
attached to the gantry stand and aligned to zero to indicate a gantry angle of zero.
The clinical plans were delivered with the actual beam angles for IMRT and
VMAT, and the angular dependence correction factors were applied to MP512-EPI
measurements (the details will discuss in Section 5.9). Each IMRT and VMAT plan was
delivered three times to justify the reproducibility of the detector measurement. Each plan
was also measured using gafchromic EBT3 film at the same orientation setup. The
composite dose measurements for MP512-corrected and EBT3 films were compared to
the calculated dose exported from RTP using gamma analysis and by following criteria
of 2%/ 2mm and 3%/3mm. The overall process of clinical validation is shown in Figure
5.14.

Figure 5.14: A schematic diagram of the clinically validated process.
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5.2.8. The correction factor
5.2.8.1. Angular dependence correction factor
The MP512-EPI was investigated to determine how the detector response could be
affected by angular dependence and to provide the maximum relative discrepancy with
respect to the incident beam angle zero of approximately 18.6% and 17.7% for 6 MV and
10 MV photon beams (refer to Chapter 4 section 4.3.8). Since the angular dependence
of MP512-EPI would affect the accuracy of the patient plan verification when using arc
therapy modalities, its angular correction method was developed and has been proven that
it can be used in small static fields due to good agreement (±2%) of the corrected dose to
dose measured with gafchromic EBT3 films, as discussed in Chapter 3.
The angular correction factor of MP512-EPI was also calculated using the same
method as MP512-Bulk (Chapter 3). The factor obtained as a function of the MP512-EPI
responding measurement ratio to the EBT3 film dose measured at Ɵ and normalised to
the zero incident beam angle (Ɵ = 0°). The dose correction of MP512-EPI was adopted
as shown in Equation (3.1) (as present in Chapter 3).

%K L
GH%IJJ
:

=

>? ′@ (A)
M @ (A)

(3.1)

where GH′: (<) is the MP512 experimental measured response signal (counts) for the
particular angle, and

: (<)

is the calibration tensor for the open 10×10 cm2 field.

The angles measured during VMAT delivery with an inclinometer were used to correct
the integral 2D-dose mapping in a particular plane. To correct the VMAT plan, the
angular correction factors were applied to accumulated MP512-EPI responses at gantry
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angle increments of 1°, 5° and 10°, respectively. The exported data files from Magic Suite
software called VMAT_angle.aux and VMAT_Decoded.txt were used for the
calculations in this study. The angles measured with an inclinometer (±180°) were
converted to the same scale as the Varian IEC scale (360°). MATLAB 2016b (Math
Works Inc., Natick, MA) was used to apply the angular correction factor to the detector
measurement and convert the detector response to a relative dose (see Appendix B for
MATLAB scripts). A schematic diagram of the angular correction factor applied to
VMAT is shown in Figure 5.15. The reconstructed composite dose of MP512-EPI for
VMAT and IMRT were compared to the EBT3 dose measurement and the TPS 2D-dose
plane.

Figure 5.15: A schematic diagram of MP512- EPI dose reconstructed for VMAT
delivery.
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5.2.8.2. Couch attenuation effect
The treatment couch can have an impact on the TPS calculation and the treatment
delivery. Some reports showed the influence that a couch build up has on skin reaction
and underestimated of the target dose by ignoring this factor when calculating and
optimising doses [239][240]. The angular correction factor discussed in section 5.9.1 was
calculated when the detector was in a vertical position, so the couch attenuation effect
was not included. To ensure that the MP512-EPI dose reconstruction calculation is
accurate, couch attenuation on patient dose verification should be investigated. The
Varian Exact image-guide (IGRT) couch (Varian Medical Systems, Palo Alto, CA) was
used. This couch was manufactured with less artefacts and radio-translucent material for
image guidance radiation therapy such as Cone beam computed tomography (CBCT), or
Megavoltage computed tomography (MVCT) [241][242]. The couch consists of 2 mm
thick carbon fibre (density of 0.7 g/cm3) wrapped around a 5.2 mm water equivalent thick
homogeneous foam core (density of 0.1 g/cm3) at 6 MV photons [243]. The couch was
manufactured from materials with different thicknesses, as shown in Figure 5.16.
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(a)

(b)
Figure 5.16: Photographs of the Varian Exact image- guide
(IGRT) couch and construction cross-section [241].

The CMRP cylindrical phantom was used to measure couch attenuation and provide the
equivalent depth for all the angles under investigation. The MP512-EPI was placed in the
centre of the phantom, 15 cm deep. The detector array faced upwards to be perpendicular
to the iso-centre of the radiation beam at a gantry angle of zero degrees (0°). Because the
IGRT couch has different thicknesses and attenuation depends on the beam’s angle of
incidence, the posterior oblique angle was measured. A 10×10 cm2 field of 6 MV photon
beams was irradiated with the gantry at four different angles; 0°, posterior (180°), and
posterior oblique (135° and 225°). To exclude the angular dependence of MP512-EPI,
the measurements were repeated with the detector face down to the couch and irradiated
with the gantry at 0°, 45°, 180° and 315°. All the gantry measurements were repeated
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three times at dose rates of 600MU/min, and 100 MU delivered. The setup is shown in
Figure 5.17. Couch attenuation was the ratio of the detector response measured with the
couch (GH512cM ) and without the couch (GH512c/I ) (Equation 5.1).

FKK SeFK IS

(a)

= ,1 −

>?P Qf

>?P Qf/5

8 ∗ 100

(5.1)

(b)

Figure 5.17: The setup used for the couch attenuation effect; (a) MP512-EPI face up
and (b) MP512-face down.

5.2.9. Gamma analysis
A gamma map analysis is a valid quantitative tool for evaluating a 2D planar doseagreement between the expected dose distribution of the treatment plan and the actual
dose distribution measurement [244]. This method was introduced by Low et al. in 1998
[245][246]. The two principal factors using for comparing the dose distribution of a
Gamma index are dose deviation (DD) or dose tolerance (∆D), and distance-to-agreement
(DTA). The point of interest is calculated within the acceptance of an ellipsoidal shape of
DD and DTA (Figure 5.18) [247]. The gamma value (γ) is computed for all the points in
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the area of interest by following Equation 5.2. The pass-fail criteria rely on the γ value,
so if γ ≤1 the calculation passes, and if γ >1 the calculation fails.
hi = jk

∆J

Dl

Q

m nk

∆L Q

m

oo

(5.2)

Where ∆r is the distance between a point on the distribution A and B, ∆d is the difference
between the dose on distribution A and B. In clinical practice, it is accepted gamma
criteria of 3%/3 mm for evaluation of dose delivered in comparison with planned. Dose
delivery is acceptable if the passing rate exceed 90% [248]. However, the small field
provides a high dose gradient leading to the fact that more robust tolerances criteria
should be considered. The MP512-EPI has a high resolution of 2 mm and to evaluate
suitability of MP512-EPI for for small field dose verification; the 2%/2mm and 1%/1mm,
gamma index were used to quantify confidence limit of MP512-EPI to be useful tool for
small field measurement. The gamma evaluation criteria using in this study were
1%/1mm, 2%/2mm and 3%/3mm with a threshold dose of 10% of the maximum.

Figure 5.18: Schematic diagram of gamma evaluation [247].
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5.3. Results
5.3.1. The couch attenuation effect
The couch attenuation value for a 10×10 cm2 field size measured by MP512-EPI showed
the average value to be within ±1.3% and a standard deviation of ±0.05 (1SD). Maximum
attenuation was 1.4% at a posterior oblique angle (135° and 225°). These results showed
that couch attenuation was within ±2% and had no effect on the MP512-EPI response.
Couch attenuation depends on the angle of the incident beam, and the field size and
photon energy [249][250]. For VMAT and IMRT, the treatments were delivered at a
segment field less than 10×10 cm2 and irradiated with an amount of treatment angles
around the patients. The detector responses had an insignificant effect on the partial couch
attenuation portion so the correction couch attenuation factors were not used to correct
the dose reconstruction of MP512-EPI.

5.3.2. Inclinometer verification
The accuracy of dose reconstruction with MP512-EPI depends on the accuracy of gantry
angle sampling during treatment delivery. Figure 5.19 shows the deviation for each gantry
measurement during beam delivery as a function of time (ms). The accuracy of the
inclinometer used in conjunction with our fast DAQ system was within ±1.5° (0.05% ),
unlike the particular data point extracted from the Dynalog files during full arc (360°)
delivery of VMAT.
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Figure 5.19: Comparison of the gantry angle measured by
the inclinometer and extracted from Dynalog files over full
arc (360°) delivery.

5.3.3. Clinical verification
5.3.2.1. Homogeneous phantom
A comparison of an MP512-EPI dose reconstruction, a gafchromic EBT3 film dose
measurement, and a planar TPS dose for IMRT and VMAT are shown in Table 5.1. These
results showed an excellent gamma passing rate of more than 95% (2%/2mm criteria) and
98% (3%/3mm criteria) for the IMRT and VMAT plans. However, a lower gamma
passing rate of 60% for all cases with criteria of 1%/1mm emerged when the MP512-EPI
dose reconstruction and EBT3 dose measurements were compared. The 1%1mm criteria
had a better gamma passing rate of 80% compared to the MP512-EPI dose reconstruction
and TPS dose calculation. Figure 5.20 shows the comparison of planar dose
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reconstruction of MP512-EPI and EBT3 film dose measurement. For IMRT delivery,
Figure 5.21 and Figure 5.22 show the x-axis and y-axis dose profiles through the isocentre
(central axis) and indicated off-axis points reconstructed from MP512-EPI measurements
with and without angular correction and EBT3 film. In all cases there was excellent
agreement between the dose profiles measured using EBT3 film and those reconstructed
from angular corrected MP512 measurements. Figure 5.23 and Figure 5.24 show the
comparison of dose profiles measured using EBT3 film and those reconstructed from
MP512-EPI measurements for the VMAT case. The gamma passing rate (2%/2mm) for
the VMAT plan delivery improved slightly as smaller gantry angles were used for the
MP512 dose reconstruction. The gamma pass rates were 95.04%, 95.23%, and 95.56%
for gantry angles used for dose reconstruction at 10°, 5° and 1°, respectively. For example,
at an off-axis of 2 cm, as shown in Figure 5.23(b) and (e), the agreement between the
angular corrected MP512 and EBT3 film measurements can be improved using smaller
angles because the dose can change rapidly over a small angular segment.

5.3.2.2. Inhomogeneous phantom
A comparison of MP512-EPI dose reconstruction, gafchromic EBT3 film dose
measurement, and planar TPS dose for IMRT and VMAT for an inhomogeneous phantom
are shown in Table 5.2, with similar results as those measured in homogeneity; they
indicated an excellent gamma passing rate of more than 95% (2%/2mm criteria) and 98%
(3%/3mm criteria) for IMRT and VMAT plans when MP512-EPI dose reconstruction
was compared with EBT3 dose measurement and TPS dose calculation. MP512-EPI dose
reconstruction compared to EBT3 dose measurements showed a lower percentage passing
rate of 70% for 1%/1mm criteria but the pass rate was more than 85% when compared
with the TPS dose calculation. Figure 5.25 shows a comparison of the planar dose
reconstruction of MP512-EPI and EBT3 film dose measurement for the VMAT plan
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delivery. Figure 5.26 and Figure 5.27 shows the x-axis and y-axis dose profiles through
the isocentre (central axis) which indicated that off-axis points were reconstructed from
MP512 measurements with angular correction and EBT3 film.

Table 5.1: Summary of the gamma passing rate of IMRT and VMAT plan delivery to
CMRP homogeneous phantom
Agreement Criteria
Cases

1%/1mm

2%/2mm

3%/3mm

MP512-EBT3

MP512-TPS

MP512-EBT3

MP512-TPS

MP512-EBT3

MP512-TPS

IMRT

69.97

89.47

96.25

98.46

98.38

100

VMAT-

56.21

82.70

95.56

98.77

99.79

100

55.28

81.39

95.23

98.77

99.79

100

53.73

80.13

95.04

98.77

99.79

100

1°sampling
corrected
VMAT5°sampling
corrected
VMAT10°sampling
corrected
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(a)

(b)
Figure 5.20: A comparison of planar dose reconstruction of MP512- EPI and
gafchromic EBT3 film dose measurement for (a) IMRT and (b) VMAT plans delivery.
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Figure 5.21: A comparison of Superior-Inferior dose profiles measured with gafchromic EBT3
films and reconstructed from MP512- EPI measurements with and without angular correction,
to deliver an IMRT plan to a homogeneous phantom as a function of distance from the centre;
( a) the beam profile at the centre, ( b) the off-axis profile above the central 2 cm, ( c) the offaxis profile above the central 1 cm, (d) the off-axis profile below the central 1 cm, and (e) the
off-axis profile below the central 2 cm.
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Figure 5.22: A comparison of Left- Right dose profiles measured with gafchromic
EBT3 films and reconstructed from MP512 measurements with and without angular
correction to deliver an IMRT plan to a homogeneous phantom as a function of distance
(mm) from the centre; (a) the beam profile at the centre, (b) the off-axis profile 2cm
right of centre, (c) the off-axis profile 1cm right of centre, (d) the off-axis profile 1cm
left of centre, and (e) the off-axis profile left 2cm left of centre.
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Figure 5.23: A comparison of Superior- Inferior dose profiles measured with
gafchromic EBT3 films and reconstructed from MP512 measurements with and
without angular correction, to deliver a VMAT plan to a homogeneous phantom as a
function of distance (mm) from the centre; (a) beam profile at the centre, (b) the offaxis profile 2cm above the centre, (c) the off-axis profile 1cm above the centre, (d) the
off-axis profile 1cm below centre, and (e) the off-axis profile 2cm below centre.
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Figure 5.24: A comparison of Left- Right dose profiles measured with gafchromic
EBT3 films and reconstructed from MP512 measurements with and without angular
correction to deliver a VMAT plan to a homogeneous phantom as a function of distance
(mm) from the centre; (a) beam profile at the centre, (b) the off-axis profile 2cm right
of centre, (c) the off-axis profile 1cm right of centre, (d) the off-axis profile 1cm left
of centre, and (e) the off-axis profile 2cm left of centre.
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Table 5.2: Gamma passing rate of IMRT and VMAT for a CMRP inhomogeneous
phantom
Agreement Criteria
Cases

1%1mm

2%/2mm

3%/3mm

MP512-EBT3

MP512-TPS

MP512-EBT3

MP512-TPS

MP512-EBT3

MP512-TPS

IMRT

69.97

89.47

96.90

96.17

99.40

100

VMAT-

73.53

83.33

97.06

99.17

99.12

100

72.94

83.75

97.06

99.17

99.12

100

72.65

79.58

96.76

98.33

99.12

100

1°sampling
corrected
VMAT5°sampling
corrected
VMAT10°sampling
corrected

Figure 5.25: A comparison of planar dose reconstruction of MP512- EPI and
gafchromic EBT3 film dose measurement to deliver VMAT plans.
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Figure 5.26: A comparison of Superior- Inferior dose profiles measured with
gafchromic EBT3 films and reconstructed from MP512 measurements with an angular
correction for a VMAT plan delivered to an inhomogeneous phantom as a function of
distance (mm) from the centre; (a) beam profile at the centre; (b) the off-axis profile
1. 5cm right of centre, ( c) the off- axis profile 1cm right of centre, ( d) the off- axis
profile 1cm left of centre, and (e) the off-axis profile 1.5cm left of centre.
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Figure 5.27: A comparison of Left- Right dose profiles measured with gafchromic
EBT3 films and reconstructed from MP512 measurements with angular correction for
a VMAT plan delivered as a function of distance ( mm) from the centre; ( a) beam
profile at the centre, (b) the off-axis profile 2cm right of centre, (c) the off-axis profile
1cm right of centre, ( d) the off- axis profile 1cm left of centre, and ( e) the off- axis
profile 2cm left of centre.
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5.4. Conclusions
To compare a clinical plan, the percentage passing rate of IMRT compared to gafchromic
EBT3 film and RTP dose calculation was almost 95% and 100% when following the
2%/2mm and 3%3mm gamma criteria for homogeneous and heterogeneous phantoms.
With VMAT, the agreement between angular corrected MP512-EPI dose reconstruction
and EBT3 film measurements can be improved using a smaller angular sampling interval
because the dose can change rapidly over a small angular segment (Figure 5.23 and Figure
5.26). The accuracy of dose reconstruction with MP512-EPI depends on the accuracy of
gantry angle sampling during treatment delivery, but with VMAT plans, the four degree
control points of TPS dose optimisation were not a fine enough sampling point to perform
different percentage passing rates when the MP512-EPI dose reconstructions, EBT3 films
dose measurements, and RTP dose calculation were compared. The homogeneous and
heterogeneous phantom measurements showed a lower agreement between MP512-EPI
dose reconstruction and EBT3 films dose measurement than the TPS dose calculation for
a gamma passing rate of 1%/1mm criteria. The set-up error may influence this result
because EBT3 films positioned in the holder could experience misalignment during setup
due to the holder being configured and the small gap shown in Figure 5.13; moreover the
small radiation field in the heterogeneous medium means that the accuracy of the dose
calculation algorithms is more important. The accuracy of dose perturbations within the
inhomogeneity and at the interface region between two different mediums depends on the
secondary electron transport modelling used during optimisation and calculation.
Pinnacle3 uses a convolution superposition algorithms so it tends to underestimate the
dose to a low-density medium such as lung tissue [234][251], but the agreements between
MP512-EPI dose reconstruction and TPS dose calculation were almost 98% at a tolerance
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of 2%2mm, and maintained more than 99% at a tolerance of 3%/3mm, which could be
acceptable for clinical practice.
These results demonstrated the clinical feasibility and accuracy of MP512-EPI as
a real-time dosimetry QA tool with a high spatial resolution for small fields (less than
5x×5 cm2) as used for SBRT. The QA procedure is practical and convenient for routine
patient specific verification for small intensity modulated fields. Future work will be
devoted to the development of a Quadro MP512-EPI detector comprised of four tiled
MP512-EPI to allow for a sensitive area 10×10 cm2 while maintaining the same spatial
and temporal resolution.
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3D dose reconstruction using MP512EPI
6.1. Introduction
Current patient specific verification using 2D dose distributions comparison between the
treatment planning (TPS) dose calculation and dose measurement in the phantom is the
primary choice in approach to QA in IMRT and VMAT delivery. However, the 2D
gamma agreement has weak correlation to be clinically meaningful, so 3D dose
distribution verification was introduced as a powerful QA tool for advanced treatment
delivery because the results can be correlated with the clinical dose distribution histogram
(DVH). In principle, the actual 3D dose can only be measured by polymer gel developed
from radiation-sensitive materials. The other commercial 3D dose distribution
measurement in a phantom such as DELTA4®, ArcCheck, and OCTAVIUS® 4D systems
are known as a Quasi-3D dose reconstruction. DELTA4® and ArcCheck have a specific
detector arrangement and reconstruct 3D dose measurements using the dose relative to
the treatment planning dose calculation [139][144]. OCTAVIUS® 4D system is an
independent QA tool that can calculate 3D dose distribution using the independent simple
data input of a 2D planar detector array measure combination with a rotating phantom
that rotates perpendicular to the irradiation beam delivery [227]. Although these devices
have good results, 3D dose reconstruction based on coarse detector density (5 mm -10
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mm) might not be suitable as the QA tool for small field dosimetry such as SRS and
SBRT delivery.
This chapter extends the study described in Chapter 5, which demonstrated the
excellent agreement of 2D dose distribution measurement using the MP512-EPI
comparison to gafchromic EBT3 films and TPS dose calculation. This chapter aims to
introduce the use of MP512-EPI as an independent 3D dose distribution reconstruction
QA device for small field dosimetry based on the dose calculation method proposed by
Allgaier et al. [149]. The second purpose is to review and discuss the potential of dataset
measured by MP512-EPI and used for clinical 3D dose reconstruction.

6.2. Theoretical background of 3D dose reconstruction
The critical aspect of modelling the dose distribution in a patient is the interpolation and
correction of measured data. ArcCheck and DELTA4® using the 3D dose reconstruction
that related to the TPS planning. ArcCheck combine with 3DVH software to reconstruct
3D dose distribution using the algorithm call ArcCheck Planar Dose perturbation
(ACPDP). Due to the detector of ArcCheck placed on the cylindrical surface, the dose
inside the phantom is estimated by convolving TERMA and 3D_kernel using the
measured dose at entry and exit detector. Each dose voxel inside the phantom
renormalizes to the same dose voxel calculated from the TPS then use those ratio data to
generate 3D dose distribution [252]. The 3D dose verification and its comparison with
dose predicted by TPS also provided by DELTA4® system. DELTA4® generate dose along
radiation rays path by renormalizing the TPS calculation to fit the measured dose at
intersect bi-planar diode then use this data to reconstruct 3D dose inside the phantom
[253]. Both of these systems reconstruct 3D dose distributions relying on the TPS dose
calculation dose while Octavius 4D system uses independence algorithm to reconstruct
3D dose.
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The Octavius 4D system reconstructs 3D dose distribution using 2D planar detector
(seven29, SRS1000 and 1500OC) in conjunction with a rotating able phantom
(OCTAVIUS 4D phantom). To eliminate angular dependence, the detector plane is
rotated and synchronised with the treatment gantry to keep the detector perpendicular to
the radiation beam during delivery, as shown in Figure 6.1.

(a)

(b)

Figure 6.1: OCTAVIUS® 4D system; (a) the component of OCTAVIUS® 4D system
and (b) the phantom rotates synchronised with the treatment gantry [254].
Allgaier et al. [149] investigated and demonstrated the simple algorithms of the 3D dose
reconstruction based on PDDs data. The PDDs for different field sizes were measured at
SSD 85 cm in a water phantom and implemented into the Verisoft software. The dose of
each voxel along the ray line (Dr) at a distance r was calculated to correspond to the dose
obtained from the current detector Ddet(0) at the current angle, as given by the Equation
6.1 [149][148]. With the non-central axis detector, the Tissue phantom ratio (TPR)
correction factors were applied according to Tailor et al. [255] for flattening filter beams
and Georg et al. [256] for flattening filter free beams. The dose was calculated for all
detectors and summarised for all the angular measurements.
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However, the patient densities are not as homogeneous as the phantom. The PDDs was
converted to TPRs and the depth along the ray line in the patient CT was scaled to the
depth in water. The patient dose (DCT) calculation algorithm was modified based on the
above equation and given by Equation 6.2.

MD

Where 9

K

D? ;p q =
K D? ;p
U07 =

∙k

FU07 Q
F q

m

(6.2)

and 9MD are the distance from the source to detector and current voxel;sMD =,

respectively.

6.3. Data measurement for commissioning and the factor
involved in 3D dose reconstruction
All the data measurements were carried out on a Varian Clinac iX (Palo Alto, CA) at the
Illawarra Cancer centre (ICCC), Wollongong Hospital, Australia. These measurements
were implemented using 6 MV photon beams because this energy is commonly used in
intensity modulated techniques such as IMRT and VMAT.

6.3.1. Percentage depth dose (PDD) measurement and off-axis ratio
(OAR)
The important data implementation for 3D dose reconstruction using MP512-EPI is the
PDD dataset because PDDs depend on the beam quality, depth, field size and SSD. The
beam data implemented to some TPSs or physical validation software for radiotherapy is
generally based on small ionisations or diodes measured in a water phantom, but this
technique is limited to point measurements and appropriated detector selections that will
markedly increase the inaccurate data implementation. In this study, MP512-EPI was
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used to measure and generate the dataset for each active pixel MP (ij,z,r). Theoretically, it
is problematical to measure the PDD curves in the PMMA cylindrical phantom itself
because there is no slot that can provide a different depth within the phantom except at
the isocentre depth (zphy = 15 cm). To simplify the PDDs measurement within the original
phantom, MP512-EPI was measured in a Gammex-RWI (Middleton, WI) solid water
phantom slap size 30×30 cm2 and fixing the SSD at 85 cm, which corresponds to the SSD
of a CMRP phantom. The PDDs were measured by varying the depth of the detector from
0.5 cm to 30 cm (Figure 6.2) and the irradiating the detector at field sizes from 1×1cm2
to 10×10 cm2. Although, the solid water phantom RMI has a density ;t

1.04 * ∙

wx Q ) close to water equivalent (t = 1.00 * ∙ wx Q ) the dose distribution within the
solid water phantom is not completely matched with the water phantom [257]. Moreover,
the MP512-EPI was sandwiched between 5 mm thick PMMA, so the depth measurement
must be scaled to the appropriate water-equivalent depth (zeq) as shown in the Equation
6.3, using the mass density in Table 6.1.

s

=

yz{70/

sR| tR| + s"i t"i

(6.3)

Where zsw and zpm is the depth in a solid water phantom and PMMA, and tR| and t"i is
the mass density (* ∙ wx E ) of the solid water material and PMMA, respectively.
This measurement also provides the off-axis ratio (OAR) of each pixel (MP512ij,z,r) for
depth z and field size r, where i is the active pixel in the x-direction, and j is the active
pixel in the y-direction. The off-axis ratio ( }~ :,p,J ) is the ratio between a dose for
particular points (

:,p,J )

and the dose at the central axis (

pixel ij is 13,13; this calculation is given by Equation 6.4.
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Figure 6.2: Geometry used for PDDs measured
by MP512- EPI at an SSD of 85 cm for 6 MV
photon beams.

6.3.2. Measuring the tissue maximum ratio (TMR)
The tissue maximum ratio (TMR) is the ratio between the dose measured in the phantom
at a particular depth (Dz) and the dose at maximum (Dmax) at the same distance (SAD)
[37]. TMR is insensitive to the SSD set up and depends on the depth of measurement (z)
and field size at the depth of measurement (rd). TMRs can generally be calculated by
Equation 6.5 based on the PDDs data while ignoring the peak backscatter factor (BSF),
where z is the depth of measurement, rd is the field size at the isocentric, and ℎ• is the
photon energy [258][259].
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According to Equation 6.5, PDDs with a smaller field are recommended to calculate the
TMRs because measuring PDDs with a field size of less than 3×3 cm2 is difficult in
practice because the detector must be moving, whereas TMRs can be measured with a
stationary detector. TMRs for small fields are preferred for direct measurement which is
why the TMR dataset in this study was measured in a solid water phantom using the
MP512-EPI; these measurements were for 1×1 cm2, 2×2 cm2, 3×3 cm2, 4×4 cm2, 5×5 cm2
and 10×10 cm2 fields. The MP512-EPI was placed at a source to axis distance (SAD) of
100 cm and was provided with a full solid water phantom backscatter thickness of 10 cm,
while the solid water slaps above the detector were placed from 0 to 30 cm, as shown in
Figure 6.3. The TMRs that were scaled to a water-equivalent depth were compared to the
data measured by Markus (ICCC dataset) in the water phantom for field sizes from 3×3
cm2 to 10×10 cm2, whereas the TMRs for small fields of 1×1 cm2 and 2×2 cm2 were
compared to TMRs measured by the CC01 ionisation chamber and stereotactic diode field
detector (SFD), as provided by Li et al. and Cheng et al. [260], [261].

Figure 6.3: Geometry used for TMR measured by MP512- EPI at SAD of 100 cm for
6 MV photon beams.
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6.3.3. Electron density of the CMRP phantom
The PMMA cylindrical phantom was scanned with the SOMATOM (Siemens
Healthineers, Erlangen, Germany) at ICCC Wollongong hospital. Details of the scan
protocol are described in Chapter 5, section 5.2.4. The CT data provided the mass and
electron density of tissues that were involved with the accuracy of the treatment
calculation and optimisation. The CT number (NCT) or Hounsfield Units (HU) were
calculated based on the linear attenuation coefficient within the material ŠiFK ;^, ‹=

relative to the attenuation of water Š|FK J ;^, ‹=; this dose calculation can be described
as Equation 6.6 [262].

ŒMD

k

•ˆ{7 •z{70/
•z{70/

m ∗ 1000

(6.6)

HU depended on the electron density and atomic number as well as the spectra energy
used for the CT scan.
Over the past decade most treatment planning algorithms, such as the pencil beam (PB),
and the analytical anisotropic algorithm (AAA) and collapsed cone (CC) modelled the
heterogeneous correction of each voxel using an equivalent path length (EPL) based on
the mass density obtained from the CT value [263]. The CT calibration phantom with
known mass densities that are relative to human tissue was scanned to calculate the NCT
to the mass density calibration curve; a sample of the CT curve is shown in Figure 6.4.
However, the EPL method overestimated the dose for bones and air, which is why J. Seco
et al. introduced the electron density scaling method (eEPL) to correct the heterogeneous
depth in the photon dose calculation [264]. The eEPL has been shown the excellent
primary photon beams estimated within 1% for energies ranging from 4 to 20 MV; it is
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also related to the mass density (ti L ) and effective atomic number (k m

l i L

) as given

by Equation 6.7 and 6.8.
t

ˆ0ƒ

= ti

•H = ∑i

(6.7)
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Where the electron density of the medium is t
is (

ˆ0ƒ

Ž

×k m

L

l i L

ˆ0ƒ

, and the physical length of the medium

.

According to Equation 6.8 the inhomogeneous correction factor based on the PDDs data
at particular field size (r) is calculated by Equation 6.9.
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is the equivalent depth and s"ℎ— is the physical depth.

In this study, eEPL was used to scale the dose distribution and generate the lookup table
for MP512-EPI measurements combined with the CMRP phantom. Table 6.1 shows the
physical mass density and electron density of each phantom used in this study.

152

Chapter 6: 3D dose reconstruction using MP512-EPI

Figure 6.4: The NCT to mass and electron density calibration curve
normalised to water [264].
Table 6.1: Characteristic of phantom materials [264][265].
Phantom

Mass density

Zeff

(Z/A)eff

Electron density

(˜ ∙ ™š › )

(Photoelectric)

Water

1.000

7.42

0.555

1.000

Solid water phantom

1.042

8.06

0.536

1.006

White water RW3

1.045

5.71

0.536

1.009

Plastic water CIRS

1.013

7.92

0.545

0.995

Polystyrene

1.060

5.69

0.538

1.028

PMMA

1.170

6.24

0.539

1.136

relative to water

(GAMMEX-RMI457)

cylindrical

phantom

6.3.4. Equivalent square field calculation
The equivalent square radiation field is the field size that provides the same amount of
radiation attenuation and scatter as the field size given with the same SSD. The equivalent
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square is calculated to determine the appropriate PDDs and TMRs used in the dose
distribution reconstruction. The equivalent square field (Aeq) can generally be computed
using a simple equation and by following Day’s rule (if the field size has the same
area/perimeter; A/P) for a rectangular field with the width of x and side of y, as shown in
Equation 6.10 [266][259].

Q!—

}

!‡—

l

4 k? m

(6.10)

However, the IMRT and VMAT delivery that yielded the complex irregular fields must
consider the scattering irradiation portion for the equivalent square field calculation.
Several algorithms were used to calculate the irregular fields in the dose calculation
software such as the ALFARD and Clarkson method [267], but this equation is
complicated and time consuming. Equation 6.11 is based on the polar coordinate that
proved to be a valid equation for comparing the equivalent field calculation to the
experiment data [268][269]. Figure 6.5 shows the relationship between a circular field
and a rectangular field, using the polar coordinates.
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Figure 6.5: The relative field size equivalent using the polar coordinates [268].

6.3.5. Verifying the dose reconstruction for a small static field
The 3D reconstruction method using MP512-EPI in combination with a CMRP phantom
can be concluded, and is shown in Figure 6.6. The accuracy of dose reconstruction using
the implemented data (PDDs, OARs, and TMRs) measured by MP512-EPI was tested on
a static 3×3 cm2 open field at 6 MV photon beams. This size field was selected because
it is suitable for an active detector area (5×5 cm2) that could ultimately be compared to
FWHM and the penumbra. Moreover, a smaller field size could not be verified because
the smallest field size data that could implemented to the TPS (Pinnacle V9.6) at CMRP
was 3×3 cm2. The MP512-EPI was aligned at the isocentre of the CMRP phantom and
the detector was irradiated with a 100 MU dose at 600 MU/min with the gantry at zero
degrees. The cross beam profiles were reconstructed using the PDD and TMR dataset at
physical depths of 1.5, 5, 10, 20, and 25 cm, which corresponded to the water-equivalent
depth (electron densities corrected) of 1.704, 5.68, 11.36, 22.72 and 28.4, respectively.
The reconstructed cross beam profiles were compared to the dose profiles obtained from
The TPS.
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Figure 6.6: Summary of the 3D dose reconstruction based on the algorithm by Allgaier
et al. [149].

6.4. Results
6.4.1. PDDs curve and off-axis ratio (OAR)
Figure 6.7 shows the PDD curves of the central axis pixels as a function of waterequivalent depth for different size fields. The PDDs curve measured by MP512-EPI was
scaled to the water-equivalent depth using the mass density presents in Equation 6.3 and
the shape preserving interpolant function from MATLAB. The PDDs measurement using
MP512-EPI also contained the off-axis ratio dataset, as shown in Figure 6.8 and Figure
6.9. The PDD and OAR dataset will be installed as a matrix of field sizes and depths.
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Figure 6.7: Central- axis percentage depth dose ( PDD) curves measured by MP512EPI at an SSD of 85 cm and normalised to a dose at Dmax for 6 MV photon beams
ranging from 1×1 cm2 to 10×10 cm2.

Figure 6.8: The off- axis ratio ( MP13j, 10,r) measured by MP512- EPI for different size
fields at a depth of 10 cm and SSD of 85 cm.
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(a)

(b)

(c)

Figure 6.9: The off-axis ratio of field size 3 × 3cm2 for 6 MV photon beams measured
by MP512-EPI at SSD 85 cm; (a) 2D response map of the off-axis data for each pixel
MP( ij) at depth 1. 5 cm, ( b) the off- axis present in the 3D matrix and ( c) the off- axis
ratio of MP(13,j) at different depths.

6.4.2. Tissue maximum ratio (TMR) data
Figure 6.10 shows a comparison of central isocentric TMR curves measured by MP512EPI and different detectors for various size fields. The difference in percentage relative
to Dmax between MP512-EPI, the CC01 ionisation chamber, SFD, and the Markus
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chamber are shown in Table 6.2. The TMRs measured by MP512-EPI showed the average
relative error to Dmax was within ±1.5% in comparison to the reference detectors. The
maximum under estimation was 1.09% for a 10×10 cm2 field at a water-equivalent depth
of 30 cm.
Table 6.2: The relative errors (Dmax) of the tissue maximum ration (TMR) measured by
the MP512-EPI, Markus, CC01 and SFD.
Field sizes (cm × cm)
WED
1×1

2×2

3×3

4×4

5×5

10×10

(cm)
MP-CC01

MP-CC01

MP-SFD

MP-Markus

MP-Markus

MP-Markus

MP-Markus

1.5

0.00

0.00

0.00

0.00

0.00

0.00

0.00

5

0.60

-0.10

-0.30

-0.86

0.01

0.05

-0.25

10

-0.10

-0.40

0.00

-0.29

-0.27

-0.14

0.57

15

0.00

-0.60

-0.50

0.51

-0.01

-0.72

0.05

20

-0.50

-1.00

0.30

0.64

-0.38

-0.53

-0.69

25

-0.20

-0.90

0.20

0.24

-0.05

-0.69

-1.08

30

-0.60

-0.70

0.10

0.35

0.28

-0.30

-1.09

Figure 6.10: The tissue maximum ratio curves for different size fields as
measured by MP512-EPI, Markus, CC01, and SFD.
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6.4.3. Verifying the dose reconstruction for a small static field
Figure 6.11 shows a comparison of the cross beam profiles of a reconstructed dose along
the central axis (MP13,j) of a 3×3 cm2 open field for 6 MV photon beams based on PDD
and TMR dataset, where the dose was obtained from TPS at different depths. The results
showed an excellent agreement along the cross beam profiles. The dose agreements in the
centre of the beam for all depths were almost within ±2%, except for the physical depth
of 1.5 cm that had an error up to 2.3% for the dose reconstruction based on PDD data
corrected. The FWHM and penumbra for both methods showed excellent agreement
within 0.0875±0.62% and 0.0962±0.85 mm. The different agreement between TPS, PDD,
and TMR corrected methods were summarised and shown in Table 6.3.

Table 6.3: The different agreement of cross beam profiles between the reconstructed and
TPS for different physical depths.
Physical
depth (cm)

FWHM (%)

Penumbra (mm)

PDD

TMR

PDD

TMR

corrected

corrected

corrected

corrected

1.5

0.4547

-0.1414

-1.3670

0.7530

5.0

0.7911

0.9420

-1.0960

1.1540

10.0

0.1596

0.1596

-1.0760

1.0760

20.0

-0.6554

0.6115

-0.6320

0.3650

25.0

-1.2980

-0.1489

-0.4420

0.3030
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(a)

(b)

(c)

(d)

(e)
Figure 6.11: The cross beam profiles reconstructed along the central axis (MP13,j) of
a 3×3 cm2 open field for 6 MV photon beams were compared to those obtained from
TPS at a physical depth of (a) 1.5 cm, (b) 5 cm, (c) 10 cm, (d) 20 cm and (e) 25 cm.
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6.5. Conclusions
Verifying the 3D dose distribution involved many steps, such as the efficiency of the
detector, design of the phantom, the data implemented and the reconstructed algorithms.
This chapter is the primary step for reconstructing a 3D dose using MP512- EPI in
conjunction with CMRP phantom, and based on the PDD and TMR calculation methods.
In this study we found that reconstructing a 3D dose using the implemented data measured
by MP512- EPI was very accurate compared to the TPS for a static 3×3 cm2 open beam.
Reconstructing a dose using TMR data showed better agreement than PDD data,
particularly at a physical depth of 1. 5 cm because the SSD effect may have influenced
these results since we know the PDD depended on SSD. Although the PDD was measured
at SSD 85 cm, the maximum depth was not 1.5 cm (approximate water-equivalent depth
of 1. 44 cm) , and the depth close to the surface of the phantom and different scattering
from the non- flat surface may be involved. However, this study only showed the cross
beams profiles of a 3×3 cm2 field. The accuracy of the dose reconstruction for various
static size fields, especially those smaller than 3×3 cm2, as well as the complex fields,
should be verified. A high spatial resolution of 2 mm of MP512 can provide a high dose
reconstruction voxel up to 2×2×2 mm3 without using the linear interpolation method. This
characteristic of MP512- EPI makes the device superior to a commercial detector array
for reconstructing doses in small field treatment such as SRS and SBRT. The method of
reconstruction and implemented data demonstrated in this study could be further modified
and developed for complicated patient dose verification. However, the active area of
MP512- EPI is only 5×5 cm2 so obtaining a small 3D dose volume and CMRP phantom
size seems to be inappropriate. Further study of the small rotating phantom will be
developed for used in conjunction with MP512- EPI. The accuracy of the rotatable
phantom function must be investigated and the full dose measurement using the rotating
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phantom and 3D dose reconstruction within the patient CT will be verified. The dose
agreement could be moved on from 2D gamma analysis to 3D gamma or DVH- based
matric comparison.

163

Chapter 7
Conclusion and future work
Intricate treatment delivery using a small field such as SRS and SBRT is being used more
used extensively but the accuracy of dose distribution must be verified before or during
treatment. However, the criticality of a small field means that an appropriate detector and
dose algorithms to measure 2D and 3D dose distributions must be developed. This thesis
has studied and investigated a high spatial 2D detector array called MagicPlate-512 that
was developed as a verification tool for use in small fields. Two detectors were
investigated in this thesis, the MP512-Bulk and the MP512-EPI. These devices were
successfully characterised as fully dosimetric, so they were then used in conjunction with
CMRP for pre-treatment verification of IMRT and VMAT. This chapter summarises the
potential outcomes using the MP512-Bulk and MP512-EPI detectors, including a
discussion of the advantages and limitations of these device systems. This chapter also
presents future study and methods of developing these devices for small field dosimetry.

7.1 The angular dependence study
This study extended the dosimetric characterisation of MP512 presented by Abdullah et
al. [170]. The MP512-Bulk is a monolithic 2D detector array based on a p-type silicon
substrate; it has 512 sensitive pixels arranged to cover an area of 52×52 mm2 at 2 mm
pitches. Each sensitive pixel area is 0.5×0.5 mm2. The detector was investigated in terms
of the effect that field size and energy has on the angular dependence of MP512. An
angular correction factor was also developed and verified. The design of MP512 with its
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high z material and silicon bulk length of 52 mm limited its use in rotation beam delivery
where the irradiation beam is not perpendicular to the MP512 plane. The relative angular
response of the MP512-Bulk demonstrated its maximum deviation at an incident beam
angle parallel to the detector plane of up to 18.5±0.5% and 15.5±0.5% for 6 MV and 10
MV photon beams, respectively. The angular response of MP512 does not depend on the
field size but it does depend on the photon energy. The angular correction method and
correction factor with a reference field size of 10×10 cm2 showed excellent results. The
corrected cross beam profiles compared to the dose measured by EBT3 yielded
agreements to within 2% for all field sizes and all incident beam angles, except for a 1×1
cm2 for 6 MV photon beams at an incident angle of 90°. The sophisticated electron
scattering in the detector at a parallel beam angle for a small field of less than or equal to
1×1 cm2 needs further investigation using the Monte Carlo.

7.2 The dosimetric characteristics of MP512-EPI
The MP512-EPI dosimeter was developed based on the high resistivity an epitaxial layer
grown on the top of a low resistivity p+ substrate while keeping the arrangement and size
of sensitive pixels the same as the MP512-Bulk. The MP512-EPI dosimeter and fast
acquisition system based on FPGA has proven to be very useful as a QA device for small
field dosimetry. The MP512-EPI dosimeter that was fabricated on a high resistivity 100
Ω cm p-Si epitaxial layer was superior to the MP512-Bulk in terms of radiation hardness,
while keeping it full dosimetric characteristics within ±2%, unlike the reference detectors
such as the ionisation chamber and gafchromic EBT3 films. Moreover, the MP512-EPI
provided excellent long-term reproducibility within ±0.9% for one year without
recalibration. EPI-Although the MP512 response had a reduction at a minimum dose per
pulse of 2.11×10-4 Gy/pulse (SSD 370 cm) up to 8 %. At a typical dose per pulse or SAD
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set up for IMRT and VMAT delivery its response revealed it to be dose per pulse
independent. The use of MP512-EPI in conjunction with the appropriate air gap provided
accurate output factor measurements for field sizes down to 1×1 cm2. Increasing its
thickness from 470 µm (MP512-Bulk) to 535 µm (MP512-EPI) and with a resistivity
value of 100 Ω cm did not affect the relative angular response, which demonstrated the
percentage difference between two detectors to be within ±2% for both energies. The dose
per pulse dependence revealed the effect on PDD when measured by the MP512-EPI,
where the depth was more than 20 cm, but the percentage difference relative to the Dmax
comparison to IC measurement was within ±2%, and can be improve by correction with
the dose per pulse factor.

7.3. 2D and 3D dose reconstruction
The MP512-EPI dosimeter was verified as a QA device for clinical IMRT and VMAT
treatment delivery. The 2D dose distribution was measured using MP512-EPI in
conjunction with a CMRP cylindrical phantom with different material insertions. The
homogeneous and inhomogeneous insertions represented the brain and lung tissue,
respectively. Small lesions (GTV) of less than 3 cm3 were used to plan with the Pinnacle
V14. Gamma indexes of 1%/1mm, 2%/2mm and 3%/3mm were used as comparisons
between the 2D dose distribution reconstruction of MP512-EPI, RTP dose calculation,
and gafchromic EBT3 film dose measurement. The 2D dose distribution was computed
using the angular correction method set out in Chapter 3. For the VMAT case, sample
angles of 1°, 5°, and 10° were calculated and verified. The 2D dose distribution
reconstructed by MP512-EPI demonstrated excellent agreement with the TPS dose
calculation and EBT3 measurements. Due to the high spatial resolution (2 mm) of
MP512-EPI, the percentage passing rate with a tolerance of 2%/2mm was almost 95%
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for all plan deliveries. A more delicate sample angle of angular correction improved the
dose agreement at the peripheral region to provide a low dose distribution, but the 2D
dose distribution verification cannot present clinically relevant results.
The MP512-EPI dosimeter was also implemented as a 3D dose verification tool.
The implemented data and 3D dose reconstruction algorithm were developed and the
PDDs and TMRs measured by MP512-EPI in a solid water phantom demonstrated an
excellent dataset using the 3D dose algorithm based on the method introduced by Allgaier
et al. [149]. The reconstructed cross beam profiles of MP512-EPI agreed with the dose
obtained from the Pinnacle V9.6 in terms of the central dose, FWHM, and the penumbra
for all depths, but this study was only verified for a static 3×3 cm2 open field; a smaller
field and a clinical IMRT or VMAT delivery should also be validated.

7.4. Future work
The design of MP512-EPI with its small active area limited its use for fields larger than
52×52 mm2, so future work will be directed towards the development of a Quadro
MP512-EPI detector with a four tiled MP512-EPI that allows for a sensitive area 10×10
cm2 while maintaining the same spatial and temporal resolutions.
Further development of the MP512-EPI and the acquisition system would be
implemented for 3D dose distribution verification. The DVH matrix will be applied as a
comparison method. A rotating phantom would be designed and developed to fit the
MP512-EPI, it would have a suitable size and be combined with the rotation validation
system. All the data discussed in Chapter 6 will play a big role in the specific domain
development which we expect to use as a software application for the proposed a fast 3D
dose reconstruction operating in real time measurements. In addition, the validation of
3D dose reconstruction developed in this thesis using high spatial resolution 2D detectors
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placed in rotation phantom and software for that will be investigated further by
comparison of reconstructed doses with the TPS and some commercial quasi-3D dose
verification devices such as ArcCheck and Delta4. Additionally obtained 3D dose will be
compared with the actual 3D dose measurement using gel dosimetry.
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Appendix A
Autodesk drawing
The detector holders for CMRP cylindrical phantom were designed for particular
materials. The 3D design AutodeskTM AUTOCAD 2016 (California, USA) was used to
create the drawings.

A.1. MP512 holder for solid water phantom
The PMMA frame was used in conjunction with the solid water phantom in the work
described in Chapter 4.
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A.2. Inhomogeneous holder for CMRP phantom
A.2.1. Upper part
The inhomogeneous holder was designed to hold the MP512 inside the CMRP cylindrical
phantom. The redwood material represents lung tissue; it was used in the patient specific
verification described in Chapter 5.
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A.2.1. Lower part
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Appendix B
Matlab Scripts
Matlab scripts were written using Matlab 2016 ( The MathsWorks Inc. ) to manage the
MP512 data involved in Chapter 3 and Chapter 5.

B.1. Mapping function script
This script was used to map the MP512 data into matrix arrays.
function [Map ] = mappingFunction( Input )
%% read 1x512 input data from Input512.xlsx file (file name can be changed)
% Input contains a 1x512 matrix of MP512

%% read 24x24 array from map.xlsx file (file name can be changed)
Map = xlsread('map.xlsx');

%% mapping
for i = 1:1:24
for j = 1:1:24
if Map(i,j) == 0
Map(i,j) = 0;
else
%% transform 1x512 to 24x24
Map(i,j) = Input(1,Map(i,j));
end
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end
end
%% replace NaN
for i = 1:1:24
for j = 1:1:24
if isnan(Map(i,j))

Map(i,j) = 0;
end
end
end
end

B.1. Angular correction script
The scripts were used to correct the angular dependence of MP512, as described in
Chapter 3 and Chapter 5.

B.1.1. Angular sampling script
function [ samplingIndex, samplingData, convertedIndex ] = Sampling( index, data,
samplingSize)

if size(index,1) ~= size(data,1)
error('size of index and data is not compatible');
end
if size(index,2) > 1
error('index has more than 1 column');
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end
if size(data,2) ~= 512
error('data must be 512 columns')
end

%re-adjust index: for negative value do this (180 - x) + 180
fprintf('convert negative index: (180 - index) + 180\n')
fprintf('negative index: %d\n', sum(index<0));

%converted Inclinometer index corresponding to LINAC index
convertedIndex = index;
for i = 1:size(convertedIndex,1)
if convertedIndex(i,1) < 0
convertedIndex(i,1) = (180 + convertedIndex(i,1)) + 180;
end
end
%find number output row
outputRow = 360 / samplingSize;
lower = 0;
upper = samplingSize;
clear samplingIndex;
clear samplingData;
for i = 1:outputRow
samplingIndex(i,1) = lower;
samplingIndex(i,2) = upper;
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samplingData( i,: ) = sum( data( convertedIndex >= lower & convertedIndex <
upper,:));

lower = upper;
upper = upper + samplingSize;
end
end

B.1.2. Application of angular correction factor applying
dataFileName = 'InhomoVMAT/Inhomo_VMAT3_Decoded.txt'; %folder/filename
indexFileName = 'InhomoVMAT/Inhomo_VMAT3_angles.aux';
load('sumCF_6X_10de.mat');

% load('CF_6X_ctrPoint.mat');
load('ERMap_m.mat')

%% import data
data = importDecodedData512(dataFileName);
index = importIndexAngle(indexFileName);

%% adjust data

data(1, :) = []; %cut first raw due to unstable reading of inclinometer where gantry start
movement, have to check
data(:, 171)= 0; %replace zero to channel that error reading this number can be changed
depend on raw data show
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data = (data.*100)./65535; % where 65535 = 2^16 -1 (16 bit) and data is a percentage
response of data bit reading
% index(1, :) = []; %cut first raw due to unstable reading of inclinometer where gantry
strat movement

%% find baseline

BS = 10; % first part: before beam start this number can be changed
BP = 35000; %BP = second part after beam stop this number can be changed
baseline = cutBaseline(data, BS, BP);
data = data - baseline; %cut baseline each raw
%% sampling angle and cut baseline
samplingSize = 10; % this value can be change
[

samplingIndex, samplingData, convertedIndex ]

=

Sampling(

index, data,

samplingSize);

%% Begin matrix angular correction

[

correctedData2,

mapData2]

=

ApplyCorrectionFactor(

samplingData,

sumCF_6X_10de,2);
mapData2(isnan(mapData2)) = 0;
mapData2 = mapData2./ERMap_man; %ER = equivalization factor (20x20 cm2, d10)
mapData2 = mapData2 .* 0.00038; % Converted MP512 response to dose(cGy) using
FC(10x10cm2 ,d1.5cm)
[mapData2]= MP_fixNan(mapData2);
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B.2. Gamma analysis
The 2D gamma index was used to compare the dose distribution of MP512 reconstruction,
EBT3 measurements and TPS calculations. This gamma index was calculated based on
Low‘s equation.
%Run script
MP = In_VMAT2_1de_predict; %add MP512 name
MP2 = MP2:23,2:23); %wing pixel was cut

%newMP = fillDead(MP2,k);

film = VMAT1_D; %add Film name
flim2 = medfilt2(film);
flim2(1,1) = film(1,1);
flim2(1,137) = film(1,137);
flim2(137,1) = film(137,1);
flim2(137,137) = film(137,137);

[Vq_MP, Vq_wflim] = AdjustScale(film, MP2, 2,0.35278,11,1);
[

GammaMap

numpass

avg

numWithinField]

=

GammaCompare(Vq_wflim./mean(Vq_wflim(:)), Vq_MP./mean(Vq_MP(:)),41, 41,0.5,
0.03, 0.3, 0.1,10);

fprintf('-------result-------\n');
fprintf('Gamma pass-rate:%4g\n',numpass*100);
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fprintf('Average gamma :%4g\n',avg);
subplot( 1,3,1) , imagesc( film) , subplot( 1,3,2) ,imagesc( MP) , subplot( 1,3,3) ,
imagesc(GammaMap);
subplot( 1,3,1) , contour( film) , subplot( 1,3,2) ,contour( MP) , subplot( 1,3,3) ,
contour(GammaMap);
%imagesc(GammaMap);
%Adjust scale

function [Vq_MP, Vq_film] = AdjustScale(film, MP, Mpx,Fpx,exSize,exPx)

%{
%INPUT parameters and detial
film = IMRT1_fD;

% original film data

MP = comImRT1_PDnet;
Fpx=0.35278;

% original MP5121 data

% pixel size spacing of film data

Mpx=2;

% pixel size spacing of MP512 data

exSize = 20;

% output image size (i.e 20X20 mm)

exPx = 1;

% pixel size spacing of output image(i.e0.5mm)

%OUPUT
Vq_MP

% converted MP images

Vq_film

% converted film images

For example:
[Vq_MP, Vq_film] = AdjustScale(film2, newMP, 2,0.35278,20,1);
%film2 is film with median filter (3X3)
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%}
% read image size
fsize = size(film,1);
msize = size(MP,1);
% Create Mesh grid
[Mxgrid,Mygrid] = meshgrid(-1*Mpx*msize/2+(Mpx/2):Mpx:+Mpx*msize/2-(Mpx/2));
[Fxgrid,Fygrid] = meshgrid(-1*Fpx*fsize/2+(Fpx/2):Fpx:+Fpx*fsize/2-(Fpx/2));
[Nxgrid,Nygrid] = meshgrid(-1*exSize+(exPx/2):exPx:+exPx*exSize-(exPx/2));
% 2D interp
Vq_film = interp2(Fxgrid,Fygrid,film, Nxgrid, Nygrid);
Vq_MP = interp2(Mxgrid, Mygrid, MP, Nxgrid, Nygrid);

% GammaCompare
% GammaMapsub will carry the calculated gamma values for the truncated
% images. GammaMap2 will be the Gamma values for the full image.
GammaMapsub = NaN;
GammaMap = zeros(size(Image1));
% Find the threshold limits for truncation
[validmask_y validmask_x] = find(Mask);
min_x = min(validmask_x)-rad;
max_x = max(validmask_x)+rad;
min_y = min(validmask_y)-rad;
max_y = max(validmask_y)+rad;
if min_x < 1
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min_x = 1;
end
if min_y < 1
min_y = 1;
end
if max_x > size(Image1,2)
max_x = size(Image1,2);
end
if max_y > size(Image1,1)
max_y = size(Image1,1);
end
% Truncate the images to avoid needless calculations
Im1 = Image1(min_y:max_y,min_x:max_x);
Im2 = Image2(min_y:max_y,min_x:max_x);
% Shift the image by varying amounts. Determine the minimum gamma value
% for all shifts
for i=-rad:rad
for j=-rad:rad
% circshift function wraps elements from top to bottom as necessary
% The entire image is shifted at once
Im2_shift = circshift(Im2,[i j]);
dist = sqrt((res_y*i)^2 + (res_x*j)^2);
DoseDiff = Im2_shift - Im1;
% Compute the gamma map for this particular shift value
Gamma_temp = sqrt((dist./DTA_tol).^2 + (DoseDiff./Dose_tol).^2);
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% Accumulate the map of the minimum values of gamma at each point
GammaMapsub = min(GammaMapsub,Gamma_temp);
end
end
% Put the truncated gamma map back into its proper location within the full
% gamma map
GammaMap(min_y:max_y,min_x:max_x) = GammaMapsub;
% Remove any edge effects from the circular shifting by multiplying by the mask values.
This will negate any calculated gamma values around the edges of the distribution where
this effect would arise
GammaMap = GammaMap .* Mask;
% Ensure that NaN values outside the mask do not affect the calculation
GammaMap(~Mask) = 0.0;

% Compute statistics
numWithinField = nnz(Mask);
numpass = nnz(GammaMap<1 & Mask)./numWithinField;
avg = sum(GammaMap(:))./numWithinField;
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